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ABSTRACT 
 
Mitochondria have evolved from endosymbiotic ?-proteobacteria. During the 
endosymbiotic process the machinery for synthesis of the bacterial peptidoglycan layer 
was eradicated from the bacterial genome. Peptidoglycan is synthesized and maintained by 
active-site serine enzymes belonging to the penicillin-binding protein and ?-lactamase 
superfamily. Mammals harbor a conserved penicillin-binding protein and ?-lactamase 
homolog named LACTB. Recently, LACTB was validated in vivo to be causative for 
obesity.  
 
 
The aim of this thesis was to investigate the phylogeny, structure, biochemistry and cell 
biology of LACTB in order to elucidate its physiological function. We show that LACTB 
and its eukaryotic homologs are closely related to low molecular weight penicillin-binding 
proteins class B from the ?-proteobacterial division. We also provide a structural model of 
LACTB indicating that LACTB shares characteristic features common to all penicillin-
binding proteins and ?-lactamases. An N-terminal GST-LACTB fusion protein expressed 
in E. coli was recovered in significant quantities, and GST-LACTB was found to be 
properly folded. We detected that the expression level of LACTB mRNA was higher in 
high metabolic rate human tissues. We show that LACTB is a soluble protein localized in 
the mitochondrial intermembrane space. We discovered that the LACTB preprotein 
underwent proteolytic processing disclosing an N-terminal tetrapeptide motif also found in 
a set of apoptosis-inducing proteins. Finally, we reveal that LACTB can polymerize to 
form stable filaments with lengths ranging from twenty to several hundred nanometers.  
 
 
These results offer novel insight into the evolution of mitochondria. We conclude that 
LACTB and bacterial penicillin-binding proteins share a common structural function. 
LACTB filaments define a distinct microdomain in the intermembrane space implying a 
role for LACTB in the mitochondrial intermembrane space organization and 
microcompartmentalization. The implications of these findings for our understanding of 
the regulation of energy metabolism are discussed. 
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INTRODUCTION 
 
Mitochondria are key organelles essential for oxidative phosphorylation, energy 
metabolism, assemblage of iron-sulfur clusters and calcium ion homeostasis. In higher 
organisms, mitochondria also play an important role in the regulation of programmed cell 
death, apoptosis (Kroemer et al., 2007). Mitochondrial dysfunction and disturbances in the 
regulation of cell death are associated with diverse diseases including neurodegeneration 
(Lin and Beal, 2006), cardiomyopathy, cancer and metabolic syndrome (Wallace, 2005).  
 
 
Mitochondria share several conserved features with their bacterial ancestor, such as a 
circular DNA, a smaller ribosome, and a double membrane. However, during 
endosymbiosis early eukaryotes dumped the major component of the bacterial cell wall, 
the peptidoglycan layer. Peptidoglycan is synthesized and maintained by penicillin-binding 
proteins and ?-lactamases (Macheboeuf et al., 2006). In spite of the lack of peptidoglycan, 
mammals harbor a protein named LACTB that shares sequence similarity with bacterial 
penicillin-binding proteins and ?-lactamases (Smith et al., 2001).  
 
 
LACTB is an active-site serine enzyme. In 2005, when this thesis was initiated, only 
scattered fragments of information were available about LACTB’s function. LACTB had 
been identified in several mitochondrial proteome survey studies (Koc et al., 2001; Taylor 
et al.; 2003, Mootha et al., 2003), suggesting that LACTB is ubiquitously expressed in 
mammalian mitochondria. It had been shown that LACTB is regulated at both the 
transcriptional and posttranslational levels (Kim et al., 2006; Lee et al., 2007). More recent 
studies demonstrated that LACTB is modulated by an immune response triggered by a 
viral or fungal infection (He at al., 2006; Johung et al., 2007; Pujol et al., 2008). In skeletal 
muscle, LACTB mRNA expression is increased by insulin (Rome et al., 2003). Very 
recently, Lactb was validated in vivo as an obesity gene (Chen et al., 2008). Gene 
expression profiling of LACTB transgenic mice revealed that LACTB is associated with 
fatty acid metabolic pathway (Yang et al., 2009). Altogether, these findings suggest that 
LACTB is involved in metabolic processes. 
 
 
Since eukaryotes lack the synthesis machinery for peptidoglycan, the question arises as to 
what is the biochemical and physiological role(s) of LACTB in metazoans? In this study, 
bioinformatics analysis, biochemical, proteomic and molecular biology experiments were 
used to clarify the function of LACTB. 
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1. LITERATURE OVERVIEW 
The focus of this doctoral thesis is LACTB. In the first part of the literature overview the 
reader will be given a general introduction to the biology of mitochondria: an essential 
central organelle for cell life and death. In the second part of the literature overview the 
relation of LACTB with bacterial penicillin-binding proteins and ?-lactamases will be 
described. 
 
1.1. Mitochondria 
1.1.1 Evolution of mitochondria 
 
Mitochondria are semiautonomous organelles that have played a prominent role in the 
evolution of eukaryotic cells (Embley and Martin, 2006; de Duve, 2007). Mitochondria 
harbor  their  own  genome  comprised  of  a  small  circular  DNA.  In  addition,  the  
mitochondrial ribosomes and the double membrane resemble the corresponding bacterial 
ones. Based on these characteristic prokaryotic-like features, mitochondria are believed to 
have originated through endosymbiosis of ancient bacteria.  
Two versions of the endosymbiotic theory have been proposed for the origin of 
eukaryotic cells (Margulis, 1981; Cavalier-Smith, 2006). According to one version of the 
endosymbiotic theory, the eukaryotic cell ancestor was an anaerobic autotrophic 
archaebacterium. This autotrophic archaebacterium utilized hydrogen as its source of 
energy for ATP production, and either CO2, methylamine, formic acid or acetate as its 
carbon source (Martin and Muller, 1998). This version of the endosymbiotic theory 
postulates that the anaerobic ancestor of the eukaryotic cell acquired a mitochondrion 
through the capture of an aerobically respiring heterotroph, a purple non-sulphur 
bacterium, belonging to the ?-proteobacterial group (John and Whatley, 1975; Margulis, 
1981). In contrast, the other version of the endosymbiotic theory postulates that both host 
and symbiont were facultative aerobes. A phagotrophic host using oxygen and excreting 
CO2 and minerals enslaved a photosynthetic purple non-sulphur ?-proteobacteria for CO2 
fixation through phagocytosis. Furthermore, the photosynthetic purple non-sulphur ?-
proteobacteria contained precursors of mitochondrial cristae, so called chromotophores. 
The chromotophores are invaginations from the inner membrane that housed respiration 
and photosynthesis machineries (Cavalier-Smith, 2006). A consequence of the 
endosymbiotic relationship was the loss of redundant genes and the transfer of genes from 
the symbiont to the host’s nucleus.  
During evolution, the symbiont underwent genome size alterations. The symbiont’s lost 
genes were associated with regulation, transport, metabolism and photosynthesis 
suggesting that the symbiont’s ancestor was metabolically highly versatile (Boussau et al., 
2004; Cavalier-Smith, 2006). In addition, the symbiont lost genes for the peptidoglycan 
layer that is synthesized and maintained by penicillin-binding proteins and ?-lactamases 
(Massova and Mobashery, 1998).  
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Eukaryotic cells are condemned to retain mitochondria, since the cells have become 
dependent on mitochondria for vital metabolic processes. Mitochondria by contrast rely on 
their host, since most of the mitochondrial proteins are encoded by nuclear genes.  
 
1.1.2 Mitochondrial structure  
 
Mitochondria range from 1-10 ?m in size. The mitochondrial number varies from a single 
mitochondrion in retinal cell to thousands of mitochondria in hepatocytes. The 
mitochondrial shape also varies depending on the cell type, from the tubular-shaped 
mitochondria in many cell types to mitochondria that consist of sheets and have a 
spherical-shape (Perkins et al., 2001; Scheffler, 2001). A mitochondrion is delimited by a 
double membrane that divides the mitochondrion into two distinct subcompartments: the 
intermembrane space and the matrix.  
The outer mitochondrial membrane (OMM) is composed of about 50% phospholipids 
and 50% proteins. The OMM contains an abundant protein, called the voltage-dependent 
anion channel (VDAC) or porin that under physiological conditions renders the OMM 
permeable to molecules having molecular mass up to 5 kDa. VDAC belongs to the porin 
family and has a ?-barrel structure like bacterial porins. In this respect, the OMM is 
reminiscent of the outer membrane of gram-negative bacteria.  
The inner mitochondrial membrane (IMM) is composed of about 20% phospholipids 
and 80% proteins. The IMM contains a phospholipid with four fatty acyl chains, 
cardiolipin, which renders the inner membrane impermeable to ions and solutes. It is 
interesting to note that cardiolipin, found in the bacterial plasma membrane, is 
predominantly localized in IMM with minor traces in OMM (de Kroon et al., 1997; 
reviewed by Mileykovskaya and Dowhan, 2009). An impermeable inner membrane is 
essential for the maintenance of the electrochemical potential required to drive 
mitochondrial ATP synthesis. Various transporter proteins such as inner membrane 
translocase (TIM) or adenine nucleotide translocase (ANT) embedded in IMM shuttle 
proteins and metabolites between the matrix and the intermembrane space. The surface 
area of the IMM is larger than the outer membrane; therefore, the inner membrane forms 
numerous invaginations or cristae that protrude into the matrix (fig. 1) (reviewed by Zick 
et al., 2009).  
 
Fig. 1. Image of 
mitochondria. (A) Electron 
micrograph of mitochondria 
from rat liver tissue. (B) 
Schematic illustration of 
mitochondrial structure. 
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A recent model of the mitochondrial ultrastructure indicates that the IMM is divided to 
two distinct subcompartments: the inner boundary membrane and the crista membrane 
(reviewed by Manella, 2006). Thus, the crista separates the intermembrane space into two 
parts: the intracristal space and the peripheral intermembrane space (Frey et al., 2002). 
Electron tomography shows that cristae are connected to the inner boundary membrane 
forming tubular cristae junctions. Cristae junctions are hypothesized to present diffusion 
barriers for proteins and molecules such as ATP or ADP from the intracristal space to the 
peripheral part of the intermembrane space (Frey et al., 2002; Manella, 2006). It has been 
shown that the ATP synthase dimers induce curvature of the inner membrane (Strauss et 
al., 2008). Thus, the ATP synthase complex can be involved in shaping the cristae. Both 
the mitochondrial outer and inner membranes undergo remodeling during programmed cell 
death. Proteins involved in programmed cell death cause an increase in the diameter of the 
cristae junctions. The increased diameter of crista junction allows the diffusion of proteins 
into the peripheral part of the intermembrane space for further release to the cytosol 
(Scorrano et al., 2002). However, the opposite effect has been observed with cristae 
junctions narrowing during programmed cell death (Yamaguchi et al., 2008), suggesting 
that various experimental models have different effects on cristae remodeling. To 
summarize, the functional consequence of cristae junctions is microcompartmentation of 
metabolites and macromolecules inside cristae.  
The unique ultrastructural architecture of mitochondria creates a platform for their 
many vital functions. 
 
1.1.3 Mitochondrial function 
 
Mitochondria play a central role in cellular processes such as oxidative phosphorylation, 
tricarboxylic acid cycle (TCA cycle), ?-oxidation of fatty acids, apoptosis, assembly of 
iron-sulfur clusters and regulation of calcium ion homeostasis. 
 
1.1.3.1 Mitochondria in energy metabolism 
Core energy metabolism 
Mitochondria are essential for energy production required to maintain cellular functions. 
The major energy-generating metabolic pathways of cells include glycolysis, fatty acid 
oxidation, ketone body oxidation and amino acid catabolism.  
Glycolysis, the breakdown of glucose and other carbohydrates, generates NADH and a 
principal mitochondrial substrate, pyruvate. Pyruvate is further oxidized in the 
mitochondrial matrix to produce NADH and acetyl-CoA. Carbohydrates represent the 
main energy source in humans, e.g. the brain uses only glucose under normal conditions. 
Fatty acid oxidation or ?-oxidation also generates acetyl-CoA, NADH and FADH2. Fatty 
acids constitute a major fuel, particularly in resting skeletal muscle and heart. Fatty acid 
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oxidation intermediates, ketone bodies, are important sources of acetyl-CoA molecules. 
During a prolonged starvation or in diabetes, the brain uses ketone bodies as energy. In 
addition, amino acids provide energy for mitochondria. Skeletal muscle uses amino acids 
as a source of fuel during prolonged starvation and exercise. Amino acids are degraded to 
pyruvate, acetyl-CoA, acetoacetate, or intermediates of the TCA cycle. 
The TCA cycle, comprised of enzyme-catalyzed reactions, involves the final oxidation 
of metabolites deriving from carbohydrates, fatty acids, and amino acids. The acetyl-CoA 
derived from glycolysis, fatty acid oxidation and ketone body oxidation serves as the 
source of energy for the TCA cycle. The NADH and FADH2 produced in the TCA cycle 
and in the energy-generating metabolic pathways are donated to the mitochondrial electron 
transport chain (Schapira, 2002; Nelson and Cox, 2008). 
Mitochondrial electron transport chain  
The mitochondrial electron transport chain or the respiratory chain is composed of four 
multiprotein enzyme complexes and two electron-carries embedded in the IMM (Schapira, 
2002). The mitochondrial respiratory chain mediates the electron transfer from NADH or 
FADH2 to the final acceptor, molecular oxygen, producing water. Electron transport is 
coupled to the pumping of protons across the IMM into the intermembrane space, resulting 
in the generation of a proton-motive force. This proton-motive force is a combination of 
the proton concentration gradient (?pH) and the membrane electrochemical gradient (??m) 
(Mitchell, 1961). The movement of protons back into the matrix, down their concentration 
gradient,  is  coupled  to  the  phosphorylation  of  ADP  to  ATP  by  complex  V  (fig.  2).  The  
process, in which ATP is formed as a result of electron transfer from NADH or FADH2 to 
oxygen by respiratory chain, is known as oxidative phosphorylation. 
 
Fig. 2. Schematic illustration of the mitochondrial electron transport chain and ATP synthesis. 
The four complexes of the electron transport chain include: complex I, NADH-dehydrogenase, 
complex II, succinate dehydrogenase, complex III, ubiquinol-cytochrome c reductase, complex 
IV, cytochrome c oxidase, and complex V, ATP synthase. Cytochrome c and coenzyme Q reside in 
the IMM and function as an electron shuttles.  
Uncoupling of oxidative phosphorylation results when substrate oxidation by the 
mitochondrial respiratory chain is not coupled to phosphorylation. The consequence of 
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uncoupling is the production of heat instead of ATP. Uncoupling proteins (UCPs) can leak 
protons across the IMM, and hence uncouple the oxidative phosphorylation causing a 
decrease in ATP production (Harper et al., 2004). Single electrons can escape from the 
mitochondrial respiration chain leading to the formation of reactive oxygen species (ROS).  
Respiratory chain complexes form large supermolecular assemblies called respiratory 
supercomplexes or respirasomes that may function for efficient electron transport during 
respiration (Acín-Pérez et al., 2008). 
 
1.1.3.2 Other functions of mitochondria 
Urea cycle 
Mitochondria play a role in the urea cycle. Within the urea cycle excess nitrogen is 
converted into urea. Two reactions of the urea cycle take place in mitochondria: (i) 
carbomoyl phosphate formation from ammonia and (ii) citrulline formation from 
carbamoyl phosphate and ornithine.  
Biosynthetic reactions 
Mitochondria are vital for several biosynthetic pathways, including steroid, heme, and 
iron-sulfur cluster synthesis (Scheffler, 2001; Nelson and Cox, 2008).  
Cholesterol is a steroid that modulates the fluidity of biological membranes. 
Furthermore, cholesterol is the precursor of steroid hormones that regulate metabolism, 
growth and developmental processes. The steroid synthesis pathway is initiated and 
completed in mitochondria with some intermediate reactions taking place in the cytosol. 
Similarly to the steroid synthesis pathway, several reactions of the heme synthesis pathway 
take place in mitochondria. The amino acid glycine and the TCA cycle intermediate 
succinyl CoA are building blocks for porphyrin synthesis. The addition of iron to the 
center of the porphyrin ring produces heme, a prosthetic group in proteins such as 
hemoglobin, catalase, peroxidase, and cytochrome c. Iron-sulfur clusters serve as cofactors 
for several enzymes, electron carrier proteins, and play an important role in mitochondrial 
iron homeostasis. Mitochondrial iron homeostasis is maintained by the uptake of iron from 
the cytosol and the incorporation into iron-sulfur clusters and heme groups (reviewed by 
Levi and Rovida, 2008). In addition, iron is stored in mitochondria. The mitochondrial 
respiratory chain complexes contain prosthetic groups such as heme (complex II, III, IV 
and cytochrome c), iron-sulfur clusters (complex I, II, and III), or copper (complex IV).  
Ca2+ homeostasis 
The calcium ion (Ca2+) is an important intracellular messenger that modulates various 
processes such as muscle contraction, secretion of signalling molecules, respiration,  and  
cell death (reviewed by Rizzuto and Pozzan, 2006; Pizzo and Pozzan, 2007).  
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Mitochondria  are  physiological  targets  and  relay  points  in  the  intracellular  Ca2+ 
signaling due to their close contact with the largest pool of Ca2+, the endoplasmic 
reticulum (Csordas et al., 2006). It has been shown that mitochondrial membrane protein 
mitofusin 2 tethers the endoplasmic reticulum to mitochondria enabling the efficient Ca2+ 
uptake (de Brito and Scorrano, 2008). Mitochondrial Ca2+ homeostasis  is  maintained  by  
the uptake and release of Ca2+. A Ca2+-uniporter present in the IMM transports cytosolic 
Ca2+ into mitochondria and an antiporter extrudes Ca2+ back  to  cytosol  (Rizzuto  and  
Pozzan, 2006). The uptake of Ca2+ by mitochondria activates matrix dehydrogenases of the 
TCA cycle, thereby stimulating the mitochondrial energy metabolism (Devin and Rigoulet, 
2007). Under pathological conditions, an accumulation of Ca2+ within mitochondria may 
lead to the opening of the permeability transition pore ultimately causing cell death.  
 
1.1.3.3 Mitochondria in cell death 
Apoptosis 
Apoptosis, or programmed cell death, is a coordinated process when aged, damaged, or 
mutated cells are eliminated by phagocytosis (Hail et al., 2006). Necrosis, so called 
unprogrammed cell death, is caused by tissue injury, infections, toxins and inflammation. 
Apoptosis and necrosis are defined by a set of changes in cell morphology. A necrotic cell 
undergoes swelling, a disruption of the plasma membrane, and cell lysis leading to tissue 
inflammation. An apoptotic cell undergoes shrinkage, chromatin condensation, DNA 
fragmentation, and budding of the plasma membrane into so called apoptotic bodies.  
Apoptosis plays a central role in embryonic development, morphogenesis, tissue 
homeostasis, and the immune system (reviewed by Meier et al., 2000). Biochemical 
features of apoptosis and genes encoding apoptosis have been extensively studied in 
several model organisms including sponge (Geodia cydonium), yeast (Saccharomyces 
cerevisiae),  hydra  (Hydra vulgaris),  nematode  (Caenorhabditis elegans),  fly  (Drosophila 
melanogaster), zebrafish (Danio rerio) and mice (reviewed by Ameisen, 2002; Oberst et 
al., 2008). Apoptosis can be divided into initiation, effector and degradation phases. Most 
of the cell’s morphological changes occur during the effector phase of apoptosis.  
The main players in the effector phase of apoptosis belong to a family of conserved 
cysteine proteases known as caspases. Since caspases promote the most visible 
ultrastructural changes characterizing apoptotic cell death, they are assigned as the central 
executioners of the apoptotic pathway. In addition, other proteases like cathepsins, 
calpains, serine proteases and the proteasome complex have been implicated as effectors of 
apoptosis (Hail et al., 2006). Two major signaling pathways can lead to caspase activation: 
(i) the extrinsic, receptor-mediated pathway and (ii) the intrinsic, mitochondria-mediated 
pathway (fig. 3) (reviewed by Kroemer et al., 2007). 
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Fig. 3. Receptor- and mitochondria-mediated pathways in mammalian cells. A family of death 
receptors e.g. CD95 are responsible for the death receptor-mediated pathway. Binding of CD95 
ligands to death receptors forms a death-inducing signaling complex. This complex recruits via the 
adaptor molecule Fas-associated death domain protein (FADD) and multiple procaspase-8 
molecules, resulting in caspase-8 activation. The mitochondria-mediated pathway is responsible 
for the release of apoptotic proteins from the mitochondrial intermebrane space. Cytochrome c 
together with the apoptotic protease activation factor-1 (Apaf-1) and procaspase-9 forms the 
apoptosome that activates effector caspases leading to apoptosis. Apoptosis inducing factor (AIF) 
and endonuclease G degrade nuclear DNA. A high-temperature requirement (Omi/HtrA2) and a 
second mitochondria-derived activator of caspases (Smac/Diablo) proteins diminish the inhibitory 
effect of inhibitor of apoptosis proteins (IAPs) which suppress the caspase cascade. Picture 
modified from Kaufmann and Hengartner, 2001 and Van Gurp et al., 2003. 
The receptor-mediated pathway involves plasma membrane proteins of the tumour 
necrotic factor receptor family. Caspase-8 activated through the receptor-mediated 
pathway cleaves a pro-apoptotic protein, called Bid. The resulting truncated Bid (tBid), in 
turn, activates the mitochondria-mediated cell death pathway. Consequently, the Bid 
protein constitutes a link between the receptor- and mitochondria-mediated pathways. 
The mitochondrial pathway involves pro-apoptotic members of the Bcl-2 family (e.g. 
Bid, Bad, Bak, and Bax) (reviewed by Youle and Strasser, 2008). tBid triggers 
conformational change of cytosolic Bax which oligomerizes and translocates to 
mitochondria (Lovell et al., 2008). The Bcl-2 family proteins act on the mitochondria and 
trigger OMM permeabilization possibly by interacting with VDAC and ANT (Zamzami 
and Kroemer, 2001; Belzacq et al., 2003). Bak, present in the OMM, together with Bax 
forms a tetrameric channel through which cytochrome c and other mitochondrial apoptotic 
proteins  are  released  (Wei  et  al.,  2001;  Van Gurp  et  al.,  2003).  In  contrast,  several  anti-
apoptotic members of the Bcl-2 family (e.g. Bcl-2 and Bcl-xL) block cytochrome c release. 
Thus, the Bcl-2 family proteins function as regulators of cell death and survival. 
Activation of the mitochondrial pathway leads to the release of soluble apoptotic 
proteins such as cytochrome c, AIF, Smac/Diablo, Omi/HtrA2, and endonuclease G from 
the mitochondrial intermembrane space to the cytosol (fig. 3). These apoptosis inducing 
proteins can be divided into two classes: caspase-dependent and caspase-independent (Van 
Gurp et al., 2003).  
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AIF causes caspase-independent apoptosis. Overexpression of AIF leads to chromatin 
condensation, DNA fragmentation, and dissipation of the mitochondrial transmembrane 
potential (Hail et al., 2006). Endonuclease G, a mitochondrial nuclease, also acts 
independently of caspases. After release from mitochondria, endonuclease G translocates 
to the nucleus where it degrades the DNA (Susin et al., 2000).  
Cytochrome c triggers apoptosis in a caspase-dependent mode (reviewed by Ow et al., 
2008). In the cytosol, cytochrome c induces caspase activation by interacting with Apaf-1 
(fig. 3). Activated Apaf-1 undergoes ATP-dependent oligomerization and then binds to 
procaspase-9. This leads to the formation of the so-called apoptosome, the caspase-9 
activation complex that cleaves pro-caspase-3. In turn, caspase-3 triggers the final stage of 
apoptosis causing characteristic changes in cell morphology. Smac/Diablo and Omi/HtrA2 
have similar roles in the apoptotic pathway. Smac/Diablo functions as a caspase-dependent 
apoptosis inducing protein (Van Gurp et al., 2003). Omi/HtrA2 is involved in both 
caspase-dependent and caspase-independent cell death. Omi/HtrA2 and Smac/Diablo 
released from the mitochondrial intermembane space contribute to cell death by 
antagonizing IAPs (fig. 3). These pro-apoptotic IAP antagonists bind to the baculoviral 
IAP repeat (BIR) domains of IAPs through their conserved N-terminal IAP binding motifs 
(IBMs) and thereby release active caspases (Verhagen et al., 2007). 
The majority of apoptosis inducing proteins exert additional functions. Evidence 
demonstrates that apoptosis inducing proteins are also involved in cell metabolism 
(Hammerman et al., 2004). For example, the pro-apoptotic Bcl-2 family member Bad plays 
a role in glucose-stimulated insulin secretion in ?-cells (Danial et al., 2008). Bax regulates 
mitochondrial morphology. Bax induces mitochondrial fusion by activating the fusion 
protein mitofusin 2 (Mfn2) (Karbowski et al., 2006), and participates in apoptotic 
fragmentation of mitochondria when it colocalizes with the fission protein dynamin-related 
protein 1 (Drp1) (Karbowski et al., 2002). Cytochrome c participates in the mitochondrial 
respiration by transferring electrons from complex III to complex IV. AIF is a flavoprotein 
the  absence  of  which  compromises  the  function  of  the  oxidative  phoshporylation  by  
affecting complex I assembly (Vahsen et al., 2004). Muscle- and liver-specific AIF 
targeted deletion protects from obesity and diabetes (Pospisilik et al., 2007). Omi/HtrA2 
functions as a chaperone at normal temperature (Spiess et al., 1999). However, under 
elevated temperatures or during cellular stress such as heat shock or ischemia, Omi/HtrA2 
shows protease activity (Gray et al., 2000). In mice, targeted deletion of Omi/HtrA2 causes 
mitochondrial dysfunction leading to symptoms characteristic for Parkinson’s disease 
(Martins et al., 2004). Recent human genetic studies, however, do not support the 
hypothesis that Omi/HtrA2 plays a role in Parkinson’s disease (Ross et al., 2008). The cell 
can undergo several distinct destruction pathways, as the loss of one apoptosis inducing 
protein can be compensated by other apoptosis inducing proteins. In support of this notion 
are the knockout models of Smac/Diablo, Omi/HtrA2 or other apoptosis inducing protein 
that had normal apoptosis (Okada et al., 2002; Martins et al., 2004; Harlin et al., 2001). In 
summary, these studies suggest that mitochondrial apoptosis inducing proteins, while 
having a primitive function in cell metabolism, were recruited during evolution for 
apoptosis. The consequences of apoptosis dysregulation include various mitochondrial 
disorders and cancer (reviewed by Meier and Vousden, 2007).  
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The mitochondrial permeability transition 
The IMM is normally impermeable to ions and solutes. However, under certain conditions 
the IMM can become unselectively permeable to molecules less than 1.5 kDa. A high 
mitochondrial Ca2+ concentration can lead to the opening of a large conductance channel, 
the permeability transition pore (PTP) formed at the contact site between the IMM and 
OMM.  Opening  of  the  PTP  causes  uncoupling  of  oxidative  phosphorylation  with  a  
collapse of the electrochemical proton gradient and abolished ATP production. Moreover, 
PTP opening is followed by Ca2+ release, mitochondrial swelling and release of 
mitochondrial intermembrane proteins involved in apoptosis (Kroemer et al., 2007). 
According to the PTP model, the core of the PTP complex is comprised of the VDAC 
in  the  OMM, the  ANT in  the  IMM and cyclophilin  D in  the  matrix.  In  addition,  several  
proteins have been shown to be associated with the PTP: the peripheral benzodiazepine 
receptor, hexokinase II, mitochondrial creatine kinase, and pro-apoptotic Bax/Bcl-2 family 
proteins (Zamzami and Kroemer, 2001). Recent studies from knockout animals indicate 
that ANT and VDAC are dispensable for the function of mitochondrial PTP (Kokoszka et 
al., 2005; Baines et al., 2007). However, it is suggested that VDAC and ANT isoforms can 
substitute each other. For example, ANT1 or VDAC2 are required for Ca2+ or tBid induced 
cell  death,  respectively  (Lee  et  al.,  2009;  Roy  et  al.,  2009).  In  summary,  these  
contradictory findings show that the PTP model requires further investigation. In contrast, 
it has been shown in mice knockout model that cyclophilin D has an essential role for PTP 
regulated cell death (Baines et al., 2005). Fibroblasts and hepatocytes from cyclophilin D 
deficient mice responded to apoptosis inducing proteins like tBid or Bax. However, 
cyclophylin D deficient fibroblasts and hepatocytes displayed resistance to ROS and Ca2+ 
overload indicating that cyclophilin D-dependent PTP modulates necrotic cell death 
(Nakagawa et  al.,  2005).  A role  of  cylophilin  D as  a  potential  cancer  treatment  target  is  
suggested by interaction of cyclophilin D with anti-apoptotic protein Bcl-2 (Eliseev et al., 
2009). Altogether, the PTP opening constitutes an essential pathway for apoptotic and 
necrotic cell death. 
 
1.1.4 Mitochondrial biogenesis 
Mitochondrial DNA  
Mitochondria contain their own genetic information, the mitochondrial DNA (mtDNA) 
which is inherited exclusively through the maternal lineage. Human mtDNA is associated 
with IMM and organized in nucleoprotein complexes, known as nucleoids, which contain 
2-8  mtDNA  copies  (Holt  et  al.,  2007).  The  copy  number  of  mtDNA  per  cell  differs  
depending on the cell type. For example, a human spermatozoa and a mature oocyte have 
102 and 105 copies of mtDNA, respectively.  
The mitochondrial genetic code is different from the universal genetic code. The 
mitochondrial genetic code of vertebrates and invertebrates differs from the universal 
genetic code in four of the 64 codons, while the mitochondrial genetic code of yeast varies 
from the universal genetic code in three of the 64 codons. One common feature of the 
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mitochondrial genome of vertebrates, invertebrates and yeast is the TGA codon that is used 
for tryptophan instead of a stop codon. In addition to the mitochondrial genetic code 
differences, the size of the mitochondrial genome also varies across the species. In plants, 
the mitochondrial genome consists of more than 200x103 base pairs, whereas, the human 
mitochondrial genome is 10 times smaller and consists of 16,569 base pairs (Scheffler, 
2001).  
The human mitochondrial genome is a circular double-stranded molecule consisting of 
a heavy strand (H) and a light strand (L). It encodes 22 transfer RNAs, 2 ribosomal RNAs, 
and 13 subunits of the mitochondrial respiratory chain complex and is devoid of introns 
and  has  only  one  non-coding  region  that  includes  a  displacement  loop  (D-loop).  The  D-
loop contains control elements for mtDNA transcription and replication: the H and L 
strand promoters, and the mtDNA H-strand replication origin. Transcription from the H 
and L strand promoters generates the polycistronic precursor RNAs that are further 
processed to yield the individual transfer RNAs, ribosomal RNAs, and messenger RNAs 
(mRNA). Most proteins involved in mammalian mtDNA replication and transcription are 
constituents of nucleoids (Wang and Bogenhagen, 2006). The importance of mtDNA 
maintainance proteins are emphasized in mitochondrial diseases associated with mtDNA 
mutations (reviewed by Tyynismaa and Suomalainen, 2009). The mtDNA mutations are 
proposed to be a major factor in cellular aging and neurodegenerative diseases (Schapira, 
2002; Kraytsberg et al., 2006).  
Mitochondrial protein import  
Nucleus-encoded mitochondrial proteins are synthesized as precursor proteins in the 
cytosol and translocated into mitochondria. The majority of precursor proteins targeted to 
the matrix, the intermembrane space and the inner membrane carry N-terminal positively 
charged presequences capable of forming basic amphipathic ?-helices. In contrast, most 
outer membrane proteins and carrier proteins of the inner membrane harbor targeting 
information within their mature sequences (reviewed by Gakh et al., 2002). The correct 
import, membrane translocation and sorting of mitochondrial proteins to different 
mitochondrial subcompartments are ensured by complex protein-import machineries 
spanning the OMM and IMM (reviewed by Baker et al., 2007; Chacinska et al., 2009).  
All precursor proteins are imported into mitochondria through the universal OMM 
translocase,  the  TOM  complex.  The  main  components  of  the  TOM  complex  include  the  
receptors Tom20 and Tom70, and the translocation channel Tom40. Tom20 is responsible 
for the targeting signal recognition, while Tom70 docks the hydrophobic precursor proteins 
(Saitoh  et  al.,  2007).  The  Tom40  subunit  acts  as  a  membrane  translocase  (Model  et  al.,  
2008). The translocation pathway through the IMM diverges to sort the precursor proteins 
to their destined mitochondrial subcompartments.  
Translocation of soluble matrix or inner membrane proteins containing N-terminal 
targeting  signals  across  the  IMM  requires  the  TIM23  complex  (Popov-Celeketic  et  al.,  
2008). In contrast, the TIM22 complex is involved in the import of inner membrane 
proteins with internal signal sequences (Peixoto et al., 2007). The import of proteins 
through the IMM is driven by the electrochemical potential (??) and the chaperone 
 
 
22 
mtHsp70 (Young et al., 2003). Precursor proteins targeted to various mitochondrial 
subcompartments are further proteolytically processed by peptidases. 
The mitochondrial processing peptidase cleaves matrix-targeting presequences, while 
the intermembrane space-sorting signals are removed by the inner membrane peptidase 
(Gakh et al., 2002). The mitochondrial intermediate peptidase performs a second cleavage 
of proteins that were initially processed by the mitochondrial processing peptidase. Many 
precursor proteins destined to the mitochondrial matrix or the inner membrane are 
processed in two steps by the mitochondrial processing peptidase and the mitochondrial 
intermediate peptidase. An inefficient processing of precursor proteins can cause 
mitochondrial diseases because the targeting signal might interfere with protein folding or 
further sorting. The mitochondrial protein-import machinery guarantees a continuous 
delivery of proteins required for mitochondrial growth and division.  
Mitochondrial fusion and fission  
Mitochondria are highly dynamic organelles, the morphology of which can be regulated by 
fusion and fission. Mitochondria undergo fusion and fission in response to different 
biological signals (reviewed by Detmer and Chan, 2007). Fusion and fission allow the 
mixing of metabolites and mtDNA required for the proliferation and distribution of 
mitochondria (Legros et al., 2004). According to a recent transient fusion model, the length 
of fusion events was sufficient to exchange soluble intermembrane space and matrix 
proteins, proposing that even transient fusion enhances functional stability of mitochondria 
(Liu et al., 2009).  
Mitochondrial fusion involves both OMM and IMM components (Detmer and Chan, 
2007). The OMM fusion is controlled by an evolutionary conserved large GTPase: Fzo1p 
in  yeast,  and  its  mammalian  homologs,  mitofusins  1  and  2  (MFN1 and  MFN2)  (Chen et  
al., 2003). The IMM fusion requires a dynamin-like GTPase: Mgm1 in yeast and its 
mammalian homolog OPA1 (Frezza et al., 2006).  
Mitochondrial fission requires a dynamin-related GTPase, Drp1 (yeast homolog 
Dnm1p) (Smirnova et al., 2001) and a small protein hFis1 (yeast homolog Fis1) (James et 
al., 2003). Drp1 from the cytoplasm is translocated to mitochondria where it binds to hFis1 
and contributes to constriction of the OMM. 
In addition to maintaining mitochondrial morphology, fission and fusion proteins 
modulate cell death. The mitochondrial fission machinery is responsible for mitochondrial 
fragmentation during apoptosis. Inhibition of Drp1 and Fis1 prevents mitochondrial 
fragmentation and delays apoptosis (Lee et al., 2004; Estaquier and Arnoult, 2007). In 
contrast, mitochondrial fusion plays a protective role in apoptosis. Apoptosis is prevented 
by overexpression of mitofusins (Sugioka et al., 2004). OPA1 regulates apoptosis by 
controlling crista remodeling and cytochrome c redistribution (Frezza et al., 2006). 
However, contradictory results suggest that cytochrome c is released without cristae 
junctions widening (Sun et al., 2007; Yamaguchi et al., 2008). Yamaguchi proposed a 
model where tBit treatment opens cristae junctions by disassembling OPA1 oligomers 
(Yamaguchi et al., 2008), disrupts cardiolipin-cytochrome c association (Kim et al., 2004) 
and releases cytochrome c through Bax/Bak pores (Lovell et al., 2008). Thus, 
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mitochondrial morphology depends on the balance between antagonistic fusion and fission 
processes.  
 
1.1.5 Mitochondria in disease 
 
Disturbances in the mitochondrial function can lead to characteristic metabolic and 
neurodegenerative disorders. A large number of factors contribute to metabolic and 
neurodegenerative mitochondrial disorders, including genetic factors, oxidative stress, 
aging, reduced oxidative phosphorylation, ?-oxidation, and altered ion homeostasis 
(reviewed by Wallace, 2005).  
Obesity and diabetes 
Obesity is a worldwide metabolic disorder associated with type 2 diabetes and 
cardiovascular diseases (reviewed by Kim et al., 2008). Obesity increases the risk to 
develop insulin resistance. Insulin resistance is defined as a decreased response by skeletal 
muscle, liver and adipose tissue to insulin. Consequently, insulin resistance leads to the 
metabolic disorder, type 2 diabetes (reviewed by Kahn et al., 2006; Muoio and Newgard, 
2008).  
Glucose homeostasis is maintained by insulin-responsive organs: skeletal muscle, liver 
and adipose tissue. Insulin secreted by pancreatic ?-cells decreases glucose production 
from liver, and increases glucose uptake, storage and utilization in skeletal muscle and 
adipose tissue. Oxidative mitochondrial metabolism plays a central role in the glucose-
stimulated insulin secretion pathway from pancreatic ?-cells. Glucose oxidation promotes 
the insulin secretion through an increased ATP production. An increased ratio of ATP to 
ADP causes the closure of ATP-sensitive K+ channels, depolarization of the plasma 
membrane, and the opening of voltage-sensitive Ca2+ channels. The resulting increase in 
the cytosolic Ca2+ concentration triggers insulin secretion (Kahn et al., 2006). In addition, a 
role for mitochondrial uncoupling protein, UPC2, in insulin secretion has been suggested 
in mice models used for studying obesity and obesity-related diabetes (Zhang et al., 2001; 
Joseph et al., 2004). These studies indicate that an increased expression of UCP2 and a 
UCP2-mediated proton leak decreases ATP production. A decreased ATP production 
impairs insulin secretion, resulting in ?-cell dysfunction and metabolic disturbances. 
However, recent studies show that overexpressed UCP3 or carnitine palmitoyltransferase-
1, which is involved in long chain fatty acyl CoA transport to mitochondria (reviewed by 
Kerner and Hoppel, 2000), have a protective role in insulin resistance (Choi et al., 2007; 
Bruce et al., 2009). 
According to one model, defects in glucose transport and lipid metabolism impair the 
insulin signaling pathway. The insulin signaling cascade is inhibited by fatty acid 
metabolites. Fatty acid metabolites deriving from adipocytes are elevated by stress or 
excess nutrient intake (Bergman and Ader, 2000). Accumulation of fatty acid and lipid 
metabolites such as fatty acyl-CoAs, diacylglycerol, and ceramide, activates 
serine/threonine kinases that phosphorylate the insulin receptor substrate family members 
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(Itani et al., 2002; Bandyopadhya et al., 2006; Holland et al, 2007). Phosphorylated insulin 
receptors cause increased glucose production in liver, reduced glucose uptake in the 
skeletal muscle and finally insulin resistance (fig. 4) (Lowell and Shulman, 2005). 
Whereas, alternative obesity studies suggest that increased rates of fatty acid oxidation and 
mitochondrial overload of lipids contribute to insulin resitance (Koves et al., 2008). 
 
 
Fig. 4. The molecular mechanism of insulin resistance in (A) skeletal muscle and (B) liver. (A) 
Intracellular long-chain fatty acyl CoA (LCFA-CoA) and diacylglycerol (DAG) levels are 
increased due to the increased delivery from plasma or from decreased mitochondrial ?-oxidation, 
caused by mitochondrial dysfunction. Increased levels of LCFA-CoA and DAG activate 
serine/threonine kinases such as protein kinase C. The activated kinases phosphorylate the serine 
residue of the insulin receptor substrate-1 (IRS-1) and inhibit insulin-induced phosphatidylinositol 
3-kinase (PI3K). Inhibition of PI3K results in a reduction of insulin-stimulated protein kinase B 
(Akt) activity. Decreased Akt activity results in suppression of insulin-stimulated glucose transport 
through GLU4 transporter. Consequently, this leads to a reduced insulin-induced glucose uptake 
and glycogen synthesis. (B) Serine/threonine kinases are activated by an increased level of DAG 
due to an increased delivery of fatty acids from plasma or an increased de novo lipid synthesis, or 
from impaired ?-oxidation. Activated serine/threonine kinases reduce insulin receptor kinase 
activity and impair IRS-2 tyrosine phosphorylation, leading to a reduced Akt activity and increased 
gluconeogenesis. Picture modified from Morino et al., 2006. 
In  obesity  and  type  2  diabetes,  the  increased  release  of  hormones  such  as  leptin  and  
adiponectin from adipose tissue is associated with insulin resistance (Scherer, 2006). 
Moreover, in obese individuals an increased release of the proinflammatory cytokines 
tumour necrosis factor-?, interleukin-6, and C-reactive protein might lead to inflammation 
and insulin resistance (reviewed by Schenk et al., 2008).  
Several genes associated with obesity and diabetes have been identified (O’Rahilly and 
Farooqi, 2006; Barrosos, 2005). Leptin is the most extensively investigated obesity gene. 
Leptin acts through the central nervous system to regulate food intake and energy 
expenditure (Friedman and Halaas, 1998). Genome-wide association studies have 
identified novel genetic variants that could contribute to the development of type 2 
diabetes. Type 2 diabetes-associated variants are located near genes such as cyclin-
depended kinase 5, fat mass and obesity associated protein, and insulin-like growth factor 
2 binding protein 2 (Zeggini et al., 2007; Scott et al., 2007). Recently several studies of 
gene networks have identified candidate genes for obesity, including zinc finger protein 90, 
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lipoprotein lipase (Lpl), protein phospatase 1-like (Ppm1l), and LACTB (Schadt et al., 
2005; Chen et al., 2008). Lpl, Ppm1l and Lactb were validated as obesity genes in mice 
knockout and transgenic models, respectively. Besides, environmental factors such as an 
increased energy intake and decreased energy expenditure influence the development of 
obesity (Kahn et al., 2006). 
Oxidative stress and aging 
Oxidative stress is defined as an imbalance between the production and the elimination of 
ROS. Mitochondria are both targets and sources of ROS. Complex I and complex III of the 
mitochondrial respiratory chain are the main production points of ROS. Accumulation of 
ROS can induce opening of the mitochondrial PTP (Lemasters et al., 1998). Cell survival 
is dependent on the antioxidant system that includes enzymatic scavengers: superoxide 
dismutase, catalase, and glutathione peroxidase. Thus, the reduced efficiency of the 
antioxidant system leads to ROS accumulation (Melov et al., 1999). 
Excessive ROS can promote oxidative damage to membrane lipids, proteins and DNA 
(Barja, 2004). The mitochondrial theory of aging postulates that the mtDNA is located in 
close proximity to the main source of ROS production. ROS damage to mtDNA impairs 
the mitochondrial respiratory chain function, which further enhances ROS generation. In 
turn, enhanced ROS generation leads to more mtDNA damage creating a vicious cycle 
(reviewed by Beckman and Ames, 1998; Finkel and Holbrook, 2000). Recently, this theory 
was challenged by studies on long-lived vertebrate species, mutants and transgenic animals 
(reviewed by Bufferenstein et al., 2008). Nevertheless, many lines of evidence demonstrate 
that an age-dependent increase in oxidative stress and mitochondria dysfunctions 
contribute to the pathogenesis of neurodegenerative diseases such as Alzheimer’s disease, 
Parkinson’s disease, Huntington’s disease and amyotrophic lateral sclerosis (reviewed by 
Lin and Beal, 2006).  
Neurodegenerative diseases 
Alzheimer’s disease (AD) is the most common neurodegenerative disorder characterized 
by a selective loss of neurons in the hippocampus and the cerebral cortex (Lin and Beal, 
2006). The pathological features of AD are extracellular amyloid plaques that contain 
cleavage products (amyloid-? (A?)) of amyloid precursor protein and intracellular 
neurofibrillary tangles components of hyperphosphorylated tau protein. Mutations in three 
genes encoding the amyloid precursor protein, presenilin 1 and 2 have been linked to AD. 
It was shown that A? inhibits respiration and enzyme activity of ?-ketoglutarate 
dehydrogenase and pyruvate dehydrogenase in isolated mitochondria (Casley et al., 2002). 
?? can directly induce oxidative stress and neuronal death through the interaction with 
mitochondrial alcohol dehydrogenase (Lustbader et al., 2004) and cyclophilin D (Du et al., 
2008). The amyloid precursor protein causes mitochondrial fragmentation in neurons by 
modulating fusion and fusion proteins (Wang et al., 2008). These observations support a 
link between mitochondria and AD.  
Parkinson’s disease (PD) is the most common neurodegenerative movement disorder 
(Lin and Beal, 2006). Selective loss of dopaminergic neurons in the substantial nigra and 
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the appearance of cytoplasmic ?-synuclein-immunoreactive inclusions, termed Lewy 
bodies, are the symptoms of PD. Mutations linked to parkinsonism include ?-synuclein, 
parkin, DJ-1 and PINK1 genes: ?-synuclein can polymerize into filaments and is found in 
Lewy bodies (Fornai et al., 2005); parkin encodes a ubiquitine E3 ligase that targets 
ubiquitine labeled substrates for degradation by the ubiquitin-proteasome pathway (Kitada 
et al., 1998) and is involved in mitochondrial autophagy (Narendra et al., 2008); DJ-1 
participates in the oxidative stress response (Bonifati et al., 2003); PINK1 maintains 
mitochondrial membrane potential and protects from apoptosis induced by proteasome 
inhibitors (Valente et al., 2004). Some of these gene products contribute to mitochondrial 
dysfunction. For example, mutated parkin and proteasome inhibition results in 
mitochondrial swelling, cytochrome c release and apoptosis (Darios et al., 2003), parkin 
and PINK1 deficiency leads to mitochondrial fragmentation (Lutz et al., 2009), while 
overexpression of ?-synuclein impairs mitochondrial activity and increases oxidative stress 
(Hsu et al., 2000). 
Huntington’s disease (HD) is an autosomal dominant neurodegenerative disease. HD is 
characterized by cognitive impairment and loss of neurons in the cortex and the striatum. 
HD is caused by multiple CAG repeat expansion in the huntingtin gene. The toxic effect of 
polyQ expansion degenerates neurons in the striatum and the cerebral cortex (Lin and Beal, 
2006). Brain mitochondria isolated from transgenic mice which express full-length 
huntingtin containing 72 CAG repeats show an impaired Ca2+ uptake and an increased 
susceptibility to the mitochondrial PTP activation (Panov et al., 2005). Mutant huntingtin 
causes mitochondrial fragmentation that is likely mediated through inhibition of 
mitochondrial fusion (Wang et al., 2009). Furthermore, the mitochondrial serine protease 
Omi/HtrA2 is involved in HD. Mouse mnd2 (motor neuron degeneration 2) phenotype has 
a mutation in Omi/HtrA2 and show common features of HD, including involuntary 
movements and massive loss of striatal neurons (Rathke-Hartlieb et al., 2002). 
Amyotrophic lateral sclerosis (ALS) leads to progressive muscle wasting and 
weakness. 90% of ALS cases are sporadic, while 10% of ALS cases are familial. 20% of 
familial ALS are caused by mutations in Cu/Zn superoxide dismutase (SOD). Mutant SOD 
forms aggregates in the intermembrane space and the matrix of brain mitochondria 
triggering mitochondrial dysfunction (Vijayvergiya et al, 2005; Magrane et al., 2009). 
However, also during normal aging SOD aggregates in motor neurons, aggregates of A? in 
AD and ?-synuclein in dopaminergic neurons result from the accumulation of misfolded 
and damaged proteins (Lin and Beal, 2006). Such protein aggregates might arise as a 
consequence of oxidative damage, mitochondrial dysfunction and impaired proteosome 
function (Glickman and Ciechanover, 2002).  
Mutations in mitochondrial proteins can also cause neurodegenerative diseases 
(reviewed by Knott et al., 2008). For example, autosomal dominant optic atrophy is 
characterized by degeneration of the optic nerve, retinal ganglion cells, and progressive 
loss of vision (Delettre et al., 2002). Mutations in the mitochondrial fission protein OPA1 
cause autosomal dominant optic atrophy. Down regulation of OPA1 by RNAi causes 
mitochondrial  fragmentation  and  leads  to  apoptosis  which  partially  explains  the  disease  
mechanism (Lee et al., 2004).  
Based on a large number of studies, it is established that neurodegenerative diseases 
involve mitochondria as a final common pathway. Thus, therapies targeting processes such 
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as ROS generation, the proteosome and mitochondrial proteins involved in diseases could 
provide a treatment for neurodegenerative diseases. 
1.2 Penicillin binding proteins and ?-lactamases 
1.2.1 Penicillin-binding proteins  
 
Penicillin-binding proteins (PBPs) form a distinct family of acyl serine transferases. PBPs 
catalyze the final steps in the synthesis of the major bacterial cell wall component, 
peptidoglycan (PG) (reviewed by Sauvage et al., 2008).  
In gram-positive bacteria, PG constitutes a thick multilayer outside the bacterial 
cytoplasmic membrane. In contrast, gram-negative bacteria have a thin layer of PG located 
in the periplasmic space between outer and inner bacterial membranes. PG confers a 
mechanic  and  osmotic  resistance  to  the  bacterial  cell  wall.  In  addition,  PG  dictates  cell  
shape since it undergoes constant chemical changes during cell growth and division 
(reviewed by Macheboeuf et al., 2006). During growth and division, bacteria can 
synthesize a new PG and hydrolyse the existing PG in order to enable an insertion of new 
material (Scheffers and Pinho, 2005). The synthesis and hydrolysis of PG require a 
coordination of several different enzymes. It was proposed and subsequently demonstrated 
by protein-protein interaction studies (von Rechenberg et al., 1996) that a multienzyme 
complex  participates  in  the  PG  synthesizing  machinery  (fig.  5).  The  PG  synthesizing  
machinery combines activities of PG hydrolases and PG synthases such as transpeptidases 
and transglycosylases.  
 
Fig. 5. Proposed model of peptidoglycan growth. A multienzyme complex synthesizes three new 
cross-linked glycan strands (grey) with the assistance of enzymes such as transpeptidase (TP), 
bifunctional transpeptidase-transglycosylase (TP/TG) and transglycosylase (TG). A multienzyme 
complex attaches these glycan strands to the cross bridges on both sides of a docking strand (single 
grey strand) and concomitantly degrades this strand. Enzymes such as lytic transglycosylase (LT) 
and endopeptidase (ED) participate in the hydrolysis process. Picture modified from Höltje, 1998.  
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The assembly of PG requires the polymerization of glycan chains composed of N-
acetylglucosoamine (NAG) and N-acetylmuramic acids (NAM). Subsequently, these 
glycan chains are cross-linked via D-alanyl-D-alanine bond of muramyl pentapeptide units 
(fig. 6) (Ghuysen, 1991; Macheboeuf et al., 2006). 
 
Fig. 6. Chemistry of the peptidoglycan synthesis. The basic unit of the PG is a disaccharide-
pentapeptide composed of amino sugars NAG and acid NAM linked together by ?-1,4 glycosidic 
bonds. PBP catalyze the (a) transglycosylation and (b) transpeptidation. The transglycosylation 
reaction involves formation of the glycosidic bonds of the PG, whereas the peptide side-chains of 
different PG strands are cross-linked by transpeptidase activity. DD-carboxypeptidases remove 
terminal D-alanine from the monomeric or dimeric disaccharide pentapeptide side-chains and DD-
endopeptidases cleave cross-linked peptide side-chains (Höltje, 1998). Meso-DAP (meso-
diaminopimelic acid) in gram-negative bacteria is changed to L-Lys in gram-positive bacteria. 
All PBPs harbor three conserved amino acid motifs: SXXK, (S/Y)XN and (K/H)(T/S)G 
(Ghuysen, 1991; Massova and Mobashery, 1998). The SXXK motif contains the active site 
serine residue that underoges acylation and deacylation cycles, and forms a covalent bond 
with substrate. The (S/Y)X(N/T) motif points to the active site cleft and participates in the 
hydrolysis. The (K/H)(T/S)G motif is involved in substrate docking.  
PBPs are grouped into two classes: the high and low molecular weight PBPs (Ghuysen, 
1991; Sauvage et al., 2008). The high molecular weight PBPs are bifunctional enzymes 
catalyzing both the transpeptidation of the peptide chains and the transglycosylation of the 
glycan strand. In contrast, the low molecular weight PBPs act as DD-carboxypeptidases 
hydrolysing the D-alanine residue of the pentapeptide. High and low molecular weight 
PBPs are further subdivided into classes A, B, and C on the basis of amino acid sequence 
similarities.  
PBPs from different classes perform different functions associated with bacterial cell 
shape and division machineries. E. coli PBP2 and PBP5 are involved in bacterial cell shape 
maintenance (Nanninga, 1998; Ghosh et al., 2008), whereas, Streptococcus PBP3 and 
Staphylococcus PBP1 are implicated in bacterial cell division (Morlot et al., 2004; Pereira 
et al., 2009).  
PBPs are target sites of penicillins and other ?-lactam antibiotics. ?-lactam antibiotics 
are compounds produced by fungi and bacteria that act by inhibiting bacterial cell wall 
synthesis. ?-lactam antibiotics acylate the active-site serine residue of PBPs thus rendering 
the PBP devoid of transpeptidase activity (Ghuysen, 1991).  
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1.2.2 ?-lactamases 
 
?-lactamases are enzymes responsible for bacterial resistance to ?-lactam antibiotics (e.g. 
penicillins and cephalosporins). ?-lactamases inactivate ?-lactam antibiotics by 
hydrolyzing the peptide bond of the ?-lactam ring rendering the antibiotic inactive (fig. 7). 
During evolution bacteria producing ?-lactamases gained a distinct survival advantage. 
However, resistance to ?-lactam antibiotics is an increasing clinical problem nowadays. 
Infections caused by resistant bacterial strains can lead to epidemics and greater risk of 
death. 
 
Fig. 7. Penicillin inactivation reaction. The reactive site of penicillin is the peptide bond of its ?-
lactam ring. Inactive penicillin is formed from the hydrolysis of the ?-lactam ring. 
?-lactamases are categorized into four classes, A, B, C and D based on the amino acid 
sequence similarity and the catalytic mechanism (Bush et al., 1995). Classes A, C, and D 
are active-site serine enzymes, whereas class B, termed metallo ?-lactamases, requires zinc 
ions (Massova and Mobashery, 1998).  
Serine ?-lactamases share structural similarities with the targets of ?-lactam antibiotics, 
the PBPs. Based on the published studies it has been accepted that serine ?-lactamases and 
PBPs emerged from the same ancestral enzyme (Ghuysen, 1994; Medeiros, 1997). 
Structure-based phylogeny of the serine ?-lactamases and PBPs indicate that the class C 
serine ?-lactamases are more similar to low molecular weight PBPs (Massova and 
Mobashery, 1998). Furthermore, the class C serine ?-lactamases predates the divergence of 
classes  A  and  D  from  the  common  ancestor  (Hall  and  Barllow,  2003).  X-ray  
crystallographic comparison of several PBPs and the class C ?-lactamases revealed 
structural similarities such as a single domain containing two regions, one ??? and one all-
helical with the catalytic site lying between them, and the three conserved amino acid 
motifs described in chapter 1.2.1 (fig. 8).  
Thus, PBPs and ?-lactamases constitute a large superfamily of active-site serine 
enzymes that are responsible for the synthesis and maintenance of PG. 
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Fig. 8. Crystal structures of (a) D-aminopeptidase from Ochrobactum anthropii (Bompard-Gilles 
et al., 2000), (b) the DD-carboxypeptidase from Streptomyces R61 (Kelly and Kuzin, 1995), (c) the 
class C ?-lactamase from Burkholderia gladioli (Wagner et al., 2002), (d) the class C ?-lactamase 
from Enterobacter cloacae P99 (Lobkovsky et al., 1993). 3-dimensional (3D) models were made 
with the program Pymol. 
 
1.3 The active-site serine protein LACTB 
 
LACTB is a homolog to bacterial PBP and ?-lactamase enzymes. LACTB has not yet been 
systematically analyzed and only some scattered information is available about its 
physiological function. LACTB was mentioned in the literature for the first time when the 
cDNA encoding LACTB was cloned from mouse liver by Smith in 2001 (Smith et al., 
2001). Mouse LACTB is a 551 amino acid long containing an active site motif related to 
class C ?-lactamases (Rawlings and Barrett, 1994). Homologues of LACTB were 
identified in several mammals, toad, fish, and nematodes, but not in yeast or fly.  
LACTB has been detected in mitochondrial proteome studies soon after the first report 
of LACTB. LACTB has been identified in the mitochondria of human and mouse heart, 
mouse brain, liver, kidney and other tissues suggesting that LACTB is a ubiquitous 
mitochondrial protein (Taylor et al., 2003; Mootha et al., 2003; Gaucher et al., 2003; 
Pagliarini et al., 2008). It has been reported that LACTB, also referred in literature as 
MRP-L56, was co-purified with the 39S subunit of the mammalian mitochondrial 
ribosome (Koc et al., 2001). LACTB was also identified in the extracellular space and 
associated with membrane fraction indicating that LACTB might be localized in other 
cellular compartments (Clark et al., 2003; Zhang et al., 2008).  
Several studies revealed that LACTB is regulated at both the transcriptional and the 
posttranslational levels. The LACTB mRNA expression was increased by insulin in human 
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skeletal muscle suggesting that LACTB might play a role in anabolic processes (Rome et 
al., 2003). LACTB is regulated at the posttranslational level by acetylation and 
phosphorylation. Lysine acetylation of LACTB occurs during starvation indicating that 
LACTB is modulated by acetyltransferases and deacetylase enzymes (Kim et al., 2006; 
Schwer et al., 2006). Conversely, the first serine residue located in the catalytic -SISK- 
motif of LACTB was phosphorylated under normal conditions suggesting that LACTB is 
activated by a specific phosphoprotein phosphatase (Lee et al., 2007). Altogether, these 
studies indicate that the LACTB function might be regulated by posttranslational 
modifications.  
Microarray analysis of murine macrophages after infection with virulent intracellular 
bacteria, Brucella melitensis, showed that Lactb was down regulated. Lactb grouped 
together with down-regulated macrophage genes involved in cell growth and metabolism 
(He  et  al.,  2006).  In  contrast,  microarray  analysis  of  HeLa  carcinoma  cells  repressed  by  
bovine papillomavirus E2 protein revealed that Lactb was induced in the senescence 
undergoing HeLa cells (Johung et al., 2007). Furthermore, a PBP homolog Lact-1 was up 
regulated in C. elegans after infection with fungus, Drechmeria coniospora (Pujol et al., 
2008). These findings propose that LACTB might also have a function in immune response 
against viral or fungal infections.  
Conclusive evidence for the role of LACTB in metabolism came when Lactb was 
validated to be a causal gene for obesity in gene network studies (Schadt et al., 2005; Chen 
et al., 2008). In Lactb transgenic mice, the fat mass to lean mass was increased by 20% 
compare to wild-type controls (Chen et al., 2008). Further characterization of Lactb 
transgenic mice revealed that LACTB is associated with fatty acid metabolism (Yang et 
al., 2009). Liver gene expression profiling of Lactb transgenic mice showed down 
regulation of fatty acid metabolic pathway. Interestingly, in genome-wide cDNA 
expression screen Lactb was identified as a repressor gene implicated in sterol regulatory 
element-binding protein pathway (Chatterjee et al., 2009). Sterol regulatory element-
binding proteins, a family of transcription factors, regulate the expression of genes 
involved the synthesis of cholesterol, fatty acids and triglycerides.  
At the time this project was started neither enzymatic substrates nor physiological 
function of mammalian LACTB were known.  
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2. AIMS OF THE STUDY 
 
The goal of this study was to investigate LACTB protein in order to elucidate its 
physiological role. 
 
The specific aims of this study were the following: 
? To  clone  the  Lactb gene for expression of LACTB protein in E. coli and 
mammalian cells for cellular biology studies. 
? To investigate the expression level of LACTB mRNA. 
? To purify the recombinant LACTB protein from E. coli and endogenous 
LACTB from rat liver mitochondria for biochemical and structural 
characterization. 
? To identify protein-protein interaction partners of LACTB. 
? To perform a phylogenetic analysis to investigate the evolutionary history 
of LACTB. 
? To perform homology modeling to generate a structural model of LACTB. 
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3. MATERIALS AND METHODS 
The methods used in this study are shortly described together with some methodological 
considerations. Further details about methods and materials are available in the original 
publications.  
3.1 Bioinformatics (II, III) 
Genomic DNA, EST, and protein data bases comprised of eukaryotic genome projects 
were searched for LACTB homologs using BLAST program. The mitochondrial targeting 
sequence was predicted using Mitoprot program. Binary amino acid alignments were made 
using DOTLET and LALIGN. Multiple alignments of amino acid sequences were made 
using ClustalW. Phylogenetic analysis was performed by maximum likelihood using the 
PROMLK program of the Phylip package. 3D structure predictions performed using the I-
TASSER server and visualized using PyMOL.  
3.2 Molecular Biology (I, III, IV) 
Polymerase chain reaction  
A  full-length  LACTB  cDNA  from  mouse  Mus musculus (clone BC046293: pCMV 
SPORT6.1-mLACTB) was amplified by the polymerase chain reaction (PCR) using 
Phusion DNA polymerase (Finnzymes). Primers used for the PCR are specified in the 
original paper I.  
Plasmid generation. Molecular cloning 
Cloning and high-level expression of tagged recombinant protein in E. coli or mammalian 
cells were performed according to the Invitrogen Instruction manual using Gateway 
technology (Invitrogen). 
Plasmids, bacterial strains and cell lines. Gateway entry and destination plasmids used for 
prokaryotic expression system or for eukaryotic expression system are summarized in table 
1. HeLa cells expressing red fluorescent protein targeted to mitochondria (mtRFP) were 
used for recombinant LACTB protein expression. Chemically competent E. coli used for 
recombinant LACTB protein expression in the prokaryotic expression system are described 
in table 2. Expression of recombinant protein is induced by isopropyl-?-D-
thiogalactopyranoside (IPTG) in E. coli strains expressing the T7 RNA polymerase.  
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Table 1. Gateway plasmids used in the experiments. 
 
Entry plasmid  
pENTR/SD/D-TOPO  
Destination plasmid Fusion tag 
pDEST 15 N-terminal GST 
pDEST 17 N-terminal His 
pDEST 24 C-terminal GST 
pET-DEST 42 C-terminal His 
pcDNA-DEST 47 C-terminal GFP 
 
Table 2. E. coli strains used in experiments. 
 
 
Gateway cloning reaction. The Gateway cloning reaction was carried out to insert the PCR 
product into the plasmid. Briefly, fresh PCR product (50-100 ng/?l) purified from 0.8% 
agarose-gel using the NucleoSpin Extract Kit (Macherey-Nagel) was mixed with 
pENTR/SD/D-TOPO entry plasmid. E. coli strain TOP10 were transformed with this 
plasmid DNA by heat shock treatment and thereafter plated onto agar plates containing 
appropriate antibiotics. After incubation overnight at +37°C, single colonies were picked 
and used to inoculate 5 ml Luria Bertani (LB) medium containing appropriate antibiotics. 
The pENTR/SD/D-TOPO plasmid DNA was purified using the NucleoSpin kit (Macherey-
Nagel) following the manufacturer’s instructions.  
Gateway recombination reaction. The Gateway recombination reaction was performed 
between the pENTR/SD/D-TOPO plasmid containing the mouse LACTB (mLACTB) 
insert and five different destination plasmids. The Gateway recombination reaction yielded 
five expression plasmids (fig. 9). E. coli strain XL2-blue was transformed with the 
recombination reaction mixture. Expression plasmid DNA was purified as mentioned 
above. E. coli strain BL21 (DE3) was transformed with this expression plasmid for 
prokaryotic expression systems. 
 
 
 
E. coli strain Application 
DB3.1 Gateway plasmids contain the toxic ccdB gene. E. coli strain DB3.1 was used to propagate 
Gateway plasmids without insert. 
TOP10 E. coli strain TOP10 alows stable replication of high-copy number plasmids and was used 
to propagate pENTR/SD/D-TOPO entry plasmid with insert. 
XL2-blue E. coli strain XL2-blue allows high-efficiency cloning and was used to obtain a high-
quality plasmid DNA. 
BL21 (DE3) E. coli strain BL21 (DE3) is designed for use with any bacteriophage T7 promoter based 
expression systems. It was used for high-level expression of recombinant protein in E. coli. 
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Fig. 9. Schematic representation of mLACTB expression plasmids used in the experiments. 
mLACTB fused to N- or C-terminal GST or His tags were used to investigate the recombinant 
mLACTB expression in E. coli. Full-length mLACTB C-terminally fused to GFP was generated for 
expression in mammalian cells. MIS-mitochondrial import sequence. 
Restriction endonuclease DNA digestion and sequencing 
Restriction endonuclease DNA digestion was performed to verify positive plasmids 
containing the mLACTB insert (New England Biolab’s manual instructions). Plasmids 
verified by restriction endonuclease DNA digestion were sent for sequencing at the 
sequencing facility of Helsinki University. DNA sequencing was carried out to verify that 
the mLACTB insert had a correct reading frame.  
Expression and purification of recombinant mLACTB  
E. coli strain BL21 (DE3) transformed with expression plasmids was cultured in LB 
medium containing appropriate antibiotic. Further protein expression and purification 
procedures are described in the original paper I.  
Analysis of LACTB mRNA expression 
The Human Multiple Tissue Expression array (BD Biosciences, Clontech) was used for 
analysis of LACTB mRNA expression. Detailed method of sample preparation and 
hybridization is described in the original paper IV.  
 
3.3 Biochemistry (III) 
Experimental animals 
Wistar rats were kept in an animal facility and treated according to the ethics guidelines of 
the European Union.  
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Liver preparations of ethanol-treated mice 
Ethanol-treated liver samples were a kind gift from Kai Lindros. Mice had been fed with 
ethanol or with a control diet for six weeks. Livers were excised and directly frozen in 
liquid nitrogen. Frozen liver was ground to powder and dissolved in SDS-PAGE sample 
buffer for LACTB protein analysis. 
Mitochondria preparations 
Isolation of mitochondria. Mitochondria were isolated from liver, kidney, lung, skeletal 
muscle, heart, brain, spleen, testis, lacrimal gland, adrenal gland, thymus and brown fat 
tissues of male Wistar rats as described in the original paper III. Mitochondria were 
isolated also from the liver of Wistar rats starved for 24 hours. 
Submitochondrial fractionation. Freshly isolated liver mitochondria were incubated with 
various concentrations of the detergent digitonin to solubilize mitochondrial membranes. 
Modified trypsin (Promega) (2 ?g/1 mg protein) was used to hydrolyze the accessible 
mitochondrial proteins.  
Separation of water soluble proteins from membrane bound proteins. 0.1 M Na2CO3 buffer 
was used to separate soluble proteins from integral membrane proteins. 
Extraction of mitochondrial intermembrane space proteins. Mitochondrial intermembrane 
space proteins were isolated by selective disruption of the outer mitochondrial membrane 
by hypo-osmotic shock using 68 mosm KPi, pH 7.4. Centrifugation at 30’000 x g for 20 
min at +4°C was carried out to separate the released intermembrane space proteins from 
the mitochondrial matrix and membrane components. The resulting supernatant was 
centrifugated at 200’000 x g for 30 min at +4°C to obtain a pellet which contains protein 
complexes with high sedimentation coefficient.  
The supernatant containing mitochondrial intermembrane space proteins was briefly 
treated with 0.1% glutaraldehyde. Glutaraldehyde cross-links proteins in close proximity to 
each other. The effect of glutaraldehyde was neutralized using a high concentration of 
glycine (100 mM). After centrifugation at 200’000 x g for 30 min at +4°C, the resulting 
pellet was layered on a discontinuous CsCl gradient. Isopycnic separation was carried out 
by centrifugation at 200’000 x g for 16 hours at +4°C. Fractions were collected for electron 
microscopy studies. 
?-Lactamase activity 
?-Lactamase activity was measured using nitrocefin (Calbiochem) as the test substrate 
according to the user’s protocol. Nitrocefin undergoes a change in absorbance from ?=390 
nm  to  ?=486  nm,  causing  a  color  change  from  yellow  to  red,  when  the  ?-lactam ring is 
hydrolyzed. Purified GST-mLACTB (5-20 ?g) and the partially purified endogenous 
LACTB from rat liver were used to determine their ?-lactamase activity. The ?-lactamase 
activity was monitored by measuring changes in absorbance at ?=486 nm on 
spectrophotometer (Parkin-Elmer). ?-lactamase from Enterobacter cloacae (Fluka) was 
used as a positive control. 
 
 
37 
Fourier transform infrared spectrometry  
The secondary structure of the protein was analyzed by Fourier transform infrared (FTRI) 
spectrometry. FTRI spectra were recorded on a Bruker Equinox 55 FTRI spectrometer 
equipped with a mercury-cadmium-telluride detector.  
Protein concentration determination 
The Bis-cinchinonic acid (BCA) assay (Pierce) was used for the colorimetric detection and 
quantitation of total protein. The BCA assay is a detergent-compatible method based on the 
alkaline reduction of the cupric ion to the cuprous ion by the protein. The Lowry method 
was used for low concentrations of protein since it is more sensitive. The Lowry method is 
based on cupric ions and Folin-Ciocalteau reagent for phenolic groups. 
 
3.4 Proteomics (I, III) 
Gel electrophoresis and immunoblotting 
Proteins were separated according to their molecular weight by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE). Proteins were electrotransferred onto 
PVDF membranes (0.2 ?m, Bio-Rad). Immunoblotting was performed to determine a 
specific protein. Immunoreactive bands were detected by chemiluminescence (Santa Cruz 
Biotechnology kit) and developed using an X-ray film processor (Fuji, Inc). Antibodies 
used for immunoblotting are specified in the original papers I and III.  
Two dimensional blue native SDS polyacrylamide gel electrophoresis  
Extracted mitochondrial intermembrane space proteins were separated by two dimensional 
blue native SDS-PAGE electrophoresis (2D BN SDS-PAGE). In the first dimension, 
proteins were separated under native conditions according to their molecular weight. In the 
second dimension, proteins were separated according to their molecular weight by SDS-
PAGE. Detailed experimental conditions of 2D BN SDS-PAGE method are described in 
the original paper III. 
Matrix-assisted laser-induced ionization-desorption and time-of-flight (MALDI-TOF) 
mass spectrometry  
Coomassie-stained bands were excised from the SDS-PAGE and 2D BN SDS-PAGE gels. 
Proteins were prepared by in-gel trypsinization method for analysis by MALDI-TOF mass 
spectrometry as described in original papers I and III. Mass spectrometry was performed 
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using a MALDI-TOF mass spectrometer (Bruker Autoflex III, Germany) at the Protein 
Chemistry Laboratory at Institute of Biomedicine, University of Helsinki.  
 
3.5 Microscopy (III) 
Electron microscopy  
Postembedding immogold labeling. Biopsy samples of rat heart, kidney, skeletal muscle, 
spleen and liver, as well as freshly isolated mitochondria were prepared by chemical 
fixation in a buffer containing 0.1 M NaPi, pH7.4, 4% paraformaldehyde, 0.2% 
glutaraldehyde, and 0.5% DMSO. Embedding, sectioning, staining and immunolabeling 
were performed according to the Tokuyasu method (Tokuyasu, 1973). Cryo-sections of the 
tissue and isolated mitochondria were viewed using a Joel 1200 EX II electron microscope. 
Whole-mount immunolabeling. Mitochondrial intermembrane space proteins separated by 
CsCl-gradient centrifugation were examined by whole-mount immunolabeling. 
Immunolabeled whole-mount samples were negatively stained with uranyl acetate. 
Samples were examined under a Philips Tecnai F20 electron microscope. Detailed methods 
of electron microscopy (EM) sample preparation are described in the original paper III.  
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4. RESULTS 
4.1 Description of LACTB  
 
Mouse LACTB is 551 amino acids long and comprised of an N-terminal predicted 
mitochondrial import segment followed by a PBP and ?-lactamase (PBP/?-lactamase) 
homology domain (fig. 10). Mouse LACTB shares around 90% amino acid identity with 
rat and human LACTB.  
 
 
 
 
 
 
 
 
 
 
 
Fig. 10. Amino acid sequence of mLACTB. Amino acids 1-30 – mitochondrial predicted targeting 
sequence; SISK, YST, HTG – catalytic site motifs. Phosphorylated serine and acetylated lysine 
marked with * (Kim et al., 2006; Lee et al., 2007).  
4.2 Amino acid and nucleotide sequence analysis of LACTB (II, 
III) 
 
Extensive analyses were performed to characterize LACTB. The human LACTB sequence 
was used to search for metazoan homologs. Metazoan proteins harboring the three active 
site motifs (-SXXK-, -(S/Y)X(N/T)-, -(K/H)(S/T)G-) of PBP/?-lactamases were classified 
as LACTB family proteins (II, table 1). LACTB orthologs were found in all completely 
sequenced vertebrate genomes. In addition, LACTB orthologs were found in Ciona 
intestinalis, Strongylocentrotus purpuratus, C. elegans and briggsae, Schistosoma 
japonicum, and Dictyostelium discoideum. 
An amino acid sequence alignment of the active site motifs and their flanking regions 
was performed. The analysis of amino acid sequence alignment showed that the active site 
motifs and several amino acids flanking the active site motifs are conserved in all analysed 
taxa from bacteria to humans (II, fig. 1A).  
Compared to bacterial PBP/?-lactamases, the metazoan LACTB orthologs harbor a 50-
100 amino acid long N-terminal extension and a 95 amino acid long insertion in the 
PBP/?-lactamase domain. Sequence analysis of metazoan LACTB orthologs with Mitoprot 
indicated that the N-terminal amino acid extension represented a predicted mitochondrial 
import sequence (II, fig. 1A). Further sequence analysis showed that mitochondrial import 
sequence directed to the matrix is followed by a sorting signal composed of hydrophobic 
MYRLLSSVTARAAATAGPAWDGGRRGAHRRPGLPVLGLGWAGGLGLGLGLALGAKLVVGLR
GAVPIQSPADPEASGTTELSHEQALSLGSPHTPAPPAARGFSRAIESSGDLLHRIKDEVGAPGIVV
GVSVDGKEVWSEGLGYADVENRVPCKPETVMRIAS*ISKSLTMVALAKLWEAGKLDLDLPVQ
HYVPEFPEKEYEGEKVSVTTRLLISHLSGIRHYEKDIKKVKEEKAYKALKMVKGTPPPPDQEKE
LKEKGGKNNEKSDTPKAKAEQDSEARCRSAKPGKKKNDFEQGELYLKEKFENSIESLRLFKND
PLFFKPGSQFLYSTFGYTLLAAIVERASGYKYLDYMQKIFHDLDMLTTVQEENEPVIYNRARFY
VYNKKKRLVNTPYVDNSYKWAGGGFLSTVGDLLKFGNAMLYGYQVGQFKNSNENLLPGYL
KPETMVMMWTPVPNTEMSWDKEGK*YAMAWGVVEKKQTYGSCRKQRHYASHTGGAVGAS
SVLLVLPEELDSEAVNNKVPPRGIIVSIICNMQSVGLNSTALKIALEFDKDRAD 
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amino acids (III, fig. 2B). Analysis of the 95 amino acid long insertion in the PBP/?-
lactamase domain revealed that the insert was enriched in charged and hydrophobic amino 
acids, having a high probability for coiled-coil formation (III, fig. 4 A, B).  
The gene structure of the metazoan LACTB orthologs was analyzed (II, fig. 1B). The 
results showed that the structure of Lactb is similar in all metazoan LACTB orthologs. In 
all vertebrates the Lactb contained six exons. These results indicate that the gene structure 
of LACTB is well-conserved. 
Next, the arrangement of the catalytic site motifs and conserved amino acids flanking 
the active site motifs in human and C. elegans LACTB  were  compared  with  a  set  of  
founding members of the each PBP/?-lactamase class (II, fig. 2). The results showed that 
LACTB  was  closely  related  to  the  class  B  of  low  molecular  weight  PBPs  (LPBP-B).  A  
sequence comparison of the PBP/?-lactamase domain of LACTB and LPBP-B proteins 
showed 16-27% sequence identity. A comparison of the LACTB amino acid sequence with 
the sequences of available crystallized LPBP-B proteins (see Literature overview section 
1.2.2, fig. 8 a-c) revealed several conserved amino acids that are important for the 
polypeptide fold formation of the 3D structure (II, additional file 2).  
 
4.3 Phylogenetic analysis of LACTB (II) 
 
To gain insight into the evolutionary history of the LACTB family proteins, phylogenetic 
analysis was performed. The amino acid sequence of the PBP/?-lactamase domain of the 
metazoan LACTB family proteins, Dictyostelium LACTB homologs, and bacterial LPBP-
B proteins were aligned. The inferred phylogenetic tree indicated that the LACTB family is 
divided into four groups which were named: LACTB orthologs, LACTB-like 1, LACTB-
like 2, and esterase-like proteins (II, fig. 3). Bacterial LPBP-B proteins were intercalated 
with the different LACTB groups, suggesting that the LACTB family comprises of four 
alloparalogus protein lineages.  
Interestingly, LACTB orthologs clustered together with LPBP-B proteins from free-
living ?-proteobacteria Maricaulis maris, Oceanicaulis alexandrii, and Sphingopyxis 
alaskensis. Similarly, esterase-like proteins clustered with a putative esterase from ?-
proteobacteria Hyphomonas neptunium. The LACTB-like group 1 and 2 proteins are 
clustered with the putative peptidases from ?-proteobacteria Bradyrhizobium japonicum 
and Mesorhizobium loti, respectively. These results suggest that the LACTB family derive 
from ?-proteobacteria. 
 
4.4 Molecular cloning and expression of recombinant LACTB 
(I) 
 
The cDNA of mLACTB was cloned for recombinant mLACTB protein expression in E. 
coli. Immunoblotting  analysis  revealed  that  E. coli expressed recombinant mLACTB 
protein (fig. 11).  
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One immunoreactive band corresponding to a molecular weight of 90 kDa was 
visualized for GST-mLACTB. However, the expression of His-mLACTB, mLACTB-GST 
or mLACTB-His resulted in multiple fragments or incorrect molecular weight products. 
MALDI-TOF mass spectrometry of the bands detected by the antibody confirmed that all 
products contained the C-terminus of the LACTB.  
 
4.5 Purification of recombinant LACTB (I) 
 
The GST-mLACTB was purified by glutathione-agarose affinity chromatography. The 
band corresponding to a molecular weight of 90 kDa was revealed on the SDS-PAGE gel 
stained  by  Coomassie  (I, fig. 1). MALDI-TOF mass spectrometry verified that this band 
contained the full-length GST-mLACTB (I, fig. 2). The yield of GST-mLACTB was about 
2 mg per liter of culture medium. 
 
4.6 Secondary structure of recombinant LACTB (I) 
 
To investigate the secondary structure of the purified GST-mLACTB, the FTIR 
spectrometry  was  performed.  The  FTIR  spectrum  showed  that  the  GST-mLACTB  was  
comprised of 29% ?-helices, 22% ?-sheets, 31% turns, and 17% random coil suggesting 
that the GST-mLACTB had an ordered secondary structure (I, fig. 3).  
 
4.7 ?-lactamase activity of LACTB  
 
The PBP/?-lactamase homology domain of LACTB contains the serine protease SXXK 
motif. Therefore, the catalytic activities of GST-mLACTB and endogenous LACTB were 
Fig. 11. Expression of recombinant mLACTB 
protein in E. coli. Immunoblot analysis of 
mLACTB recombinant protein fused to N- or C-
terminal GST or His tag. Proteins were 
separated on a 10% SDS-PAGE and the 
recombinant mLACTB protein was visualized by 
immunoblotting using the anti-LACTB antibody. 
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investigated. However, using nitrocefin as a test substrate for ?-lactamase activity no 
enzymatic activity of the GST-mLACTB and endogenous LACTB was detected. 
 
4.8 Subcellular localization of LACTB (III) 
 
Proteome survey studies have given contradictive results regarding the subcellular 
localization of LACTB. Therefore, the subcellular localization of LACTB was tested using 
rat liver. Different liver fractions were analyzed by immunoblotting with anti-LACTB 
antibody. The immunoreactivity of LACTB was detected in the mitochondrial fraction 
(III, fig. 1C).  
 
4.9 Submitochondrial localization of LACTB (III) 
 
To determine the submitochondrial localization of LACTB, the biochemical and EM 
experiments were performed. Mitochondria were permeabilized with the detergent 
digitonin and subsequently treated with trypsin. Immunoblotting showed that at a digitonin 
concentration sufficient to permeabilize the OMM (0.3 mg digitonin per mg protein) 
LACTB was effectively hydrolyzed by trypsin. The same hydrolysis effect was seen for 
the intermembrane space proteins OPA-1 and AIF, while the mitochondrial matrix protein 
Hsp60 was not affected (III, fig. 1D).  
Furthermore, immunoelectron microscopy performed on cryo-sections prepared from 
rat tissues and isolated mitochondria confirmed that LACTB was localized in the 
mitochondrial intermembrane space (III, fig. 1F and supplementary fig. S4). Statistical 
analysis of the immunogold-labeled liver cryo-sections was performed. It was found that 
83% of the nanogold particles were arranged on mitochondria, especially over the cristae.  
 
4.10 Association of LACTB to mitochondrial membranes (III) 
 
To assess the disposition of LACTB on mitochondrial membranes, mitochondria after 
hypo-osmolar incubation were treated with alkali buffer (NaCO3).  The  alkali  treatment  
caused colocalization of LACTB together with soluble protein cytochrome c, peripherally 
associated with IMM, while integral membrane proteins porin and prohibitin remained in 
membrane pellet (III, fig. 1E).  
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4.11 Expression of LACTB in mitochondria of different rat 
tissues 
 
The expression level of the LACTB protein was investigated in mitochondria isolated from 
different rat tissues. The highest LACTB protein expression levels were observed in the 
liver, testis, spleen, lacrimal and adrenal glands, and kidney mitochondria, while 
mitochondria from the thymus, lung and brown fat tissues had lower levels of LACTB 
protein (fig. 12).  
 
Fig. 12. Expression of LACTB protein in various rat tissues. Mitochondrial proteins were 
separated on a 10% SDS-PAGE and LACTB protein was visualized by immunoblotting using the 
anti-LACTB and porin antibodies (unpublished data). 
Weak immunoreactive bands of higher molecular weight were detected for the LACTB 
protein in the skeletal muscle, heart and brain mitochondria.  
 
4.12 Expression of LACTB during metabolic perturbations 
 
Several studies suggest that LACTB is involved in metabolic processes. Therefore, the 
expression level of LACTB was tested during metabolic perturbations. First, the 
expression level of LACTB was investigated in the liver of rats starved for 24 hours. 
However, no significant difference in the LACTB protein expression level was observed 
between the starved rats and the control rats. Second, the expression level of LACTB 
protein was investigated in the liver of ethanol-treated mice. Immunoblotting showed a 
profound decrease in the LACTB protein expression for mouse liver treated with an 
ethanol diet (fig. 13).  
 
Fig. 13. Effect of ethanol feeding on the 
LACTB protein expression level in the 
mouse liver. Mice were fed with an ethanol 
or a control diet for six weeks. Tissue 
samples from control and ethanol treated 
mice (n=3) were separated on a 10% SDS-
PAGE and immunoblotted with anti-LACTB 
and actin antibodies (unpublished data).  
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4.13 Expression of LACTB mRNA in various human tissues and 
cancer cell lines (IV) 
 
The relative levels of LACTB mRNA expression in human tissues and cancer cell lines 
were determined. The highest mRNA expression levels of LACTB were found in the heart, 
skeletal muscle, liver and kidney, while the lowest were found in the thyroid gland, uterus 
and  ovary  (IV, fig. 1). Fetal tissues contained lower levels of LACTB mRNA than the 
corresponding adult tissues (IV, fig. 2). Interestingly, several cancer cell lines contained 
very low levels of LACTB mRNA (IV, supplementary table 1).  
 
4.14 Analysis of LACTB protein under native and denaturing 
conditions (III) 
 
To determine the native molecular weight of LACTB and to identify protein-protein 
interaction partners of LACTB, mitochondrial intermembrane space proteins were 
separated by 2D BN SDS-PAGE. Immunoblotting using the LACTB antibody revealed a 
LACTB band ranging from 600 kDa to several MDa in the native direction of the gel (III, 
fig. 2A). In the denaturing direction, this band separated into a major 55 kDa component 
and a minor 200 kDa component. These findings suggest that LACTB is part of a high 
molecular weight complex or forms a homopolymer. 
MALDI-TOF mass spectrometry confirmed that both the 55 kDa and 200 kDa 
immunoreactive bands contained LACTB. The major 55 kDa immunoreactive band 
yielded a high-scoring MS/MS spectrum from peptides covering 47% of the amino acid 
sequence of LACTB (III, fig. 2B-D). Moreover, a MS/MS spectrum of a 3676.3 Da 
peptide was obtained. This peptide subjected to MALDI-TOF-TOF analysis could be 
assigned to the N-terminal 38 amino acid segment of LACTB starting from alanine 63 (III, 
fig. 2C).  
In order to search for proteins that might participate in a complex formation with 
LACTB, the high molecular weight region of the 2D BN SDS-PAGE gel was analyzed by 
MALDI-TOF mass spectrometry (III, fig. 2A). Proteins such as glutamate dehydrogenase, 
carbamoylphosphate synthase, and the cytosolic ribosomal proteins 60L and 40L were 
identified (III, supplementary table 1). 
 
4.15 Structural analysis of the LACTB polymer (III) 
 
Since LACTB migrated as a high molecular weight protein under native conditions, the 
possibility that LACTB forms an organized structure was investigated. The mitochondrial 
intermembrane space proteins separated by CsCl-gradient centrifugation were examined by 
transmission EM. Filaments composed of globular subunits were observed at a gradient 
density of 1.25-1.28 g/cm3 (III, fig. 3A). The length of the filaments varied from twenty to 
 
 
45 
several hundred nanometers. Immunoblotting and MALDI-TOF mass spectrometry 
confirmed that this CsCl-gradient fraction contained LACTB.  
To answer the question as to whether LACTB formed filaments, whole-mount 
immunoelectron microscopy was performed. The results showed that LACTB antibodies 
coupled to nanogold particles exclusively labeled the filaments (III, fig. 3B). To gain 
insight into the subunit organization of the filament, images of 128 subunits were aligned 
and averaged (III, supplementary fig. 3). According to the tilting and averaging, the 
subunit volume was calculated to be 360 nm3. It was calculated that this volume can 
accommodate 3-5 molecules of LACTB.  
 
4.16 Quantification of LACTB in rat liver mitochondria (III) 
 
To estimate the amount of LACTB in mitochondria, the high molecular weight region of 
the 1D BN PAGE gel was analyzed by SDS-PAGE gel electrophoresis and quantitative 
immunoblotting (III, supplementary fig. S6). Based on the intensity of Coomassie stained 
and immunolabeled 55 kDa bands, the amount of LACTB was estimated to be 20+/-6 
pmol/mg mitochondrial protein. Comparison with other mitochondrial proteins showed 
that liver mitochondria contain, on average, 1500 molecules of LACTB (III, 
supplementary table S2). These results indicate that 1500 molecules of LACTB can form 
eighteen filaments with a length of one hundred nanometers each. 
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5. DISCUSSION 
5.1 Evolution of LACTB  
 
The bacterial PBP/?-lactamase proteins are essential for the synthesis of the PG layer and 
the maintenance of cell morphology (Cabeen and Jacob-Wagner, 2005; Macheboeuf et al., 
2006; Ghosh et al., 2008). In contrast, the function of the metazoan PBP/?-lactamase 
family proteins remains largely unknown. Recent evidence suggests that the mammalian 
PBP/?-lactamase homolog LACTB (Smith et al, 2001) is involved in metabolic signaling 
(Rome et al., 2003; Kim et al., 2006; Lee et al., 2007; Chen et al., 2008). Therefore, by 
clarifying the evolutionary history of LACTB may provide clues about the function of the 
metazoan PBP/?-lactamase homologs. 
Similarity searches for LACTB in the eukaryote genome data bases revealed orthologs 
in vertebrate, tunicate, echinodermata, nematode, platyhelminthes, and mycetozoa 
genomes. However, no homologs of LACTB were found in the yeast S. cerevisiae or in 
insect D. melanogaster. All LACTB orthologs contain conserved catalytic site signature 
motifs (Ghuysen, 1991; Massova and Mobashery, 1998). Furthermore, the identification of 
several conserved amino acids flanking the active site motifs suggest that LACTB and the 
bacterial PBP/?-lactamases share common features in the secondary and tertiary structure.  
Metazoan LACTB orthologs, by contrast to bacterial PBP/?-lactamases, contain a 
predicted mitochondrial import sequence and a 95 amino acid long insertion in the PBP/?-
lactamase domain suggesting that these segments have evolved in eukaryotes. The 
predicted mitochondrial import sequence of LACTB suggests that LACTB is targeted to 
mitochondria. The 95 amino acid long insertion forms a coiled-coil alpha-helical structure. 
Coiled-coils are oligomerization motifs found in a variety of proteins that function as 
molecular  scaffolds  for  the  cell  cytoskeleton  (Rose  and  Meier,  2004).  For  example,  a  
conserved sequence of a coiled-coil structure is responsible for the polymerization of 
cytoplasmic intermediate filaments (Oshima, 2007). Based on this observation, we propose 
that the predicted coiled-coil segment might contribute to the polymerization of LACTB.  
Bacterial PBP/?-lactamases family proteins are classified according to the three 
common catalytic  site  signature  motifs,  the  specific  amino  acids  in  the  active  site  motifs  
and  the  number  of  amino  acid  residues  between  the  three  motifs  (Bush  et  al.,  1995;  
Massova and Mobashery, 1998). Comparing the arrangement of the active site motifs and 
their amino acids in metazoan LACTB with the bacterial PBP/?-lactamase classes revealed 
that LACTB derives from LPBP-B proteins. LPBPs act as D-alanyl-D-alanine 
carboxypeptidases hydrolyzing the PG (Gosh et al., 2008). LACTB groups together with 
the  LPBP-B  proteins  and  contains  the  conserved  catalytic  serine  residue  suggesting  that  
LACTB possess a peptidase or esterase activity. Therefore, LACTB can be classified as an 
active-site serine enzyme. 
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5.2 Homology model of LACTB  
 
Currently three proteins from the LPBP-B subclass have been crystallized: a D-alanyl-D-
alanine carboxypeptidase from Streptomyces R61, a D-alanyl-D-alanine aminopeptidase 
from Ochrobactrum anthropii, and a transesterase from Burkholderia gladioli (Kelly and 
Kuzin, 1995; Bompart-Gilles et al., 2000; Wagner et al., 2002). These enzymes share a 
similar polypeptide fold. Amino acid sequence alignments of LACTB with these LPBP-B 
proteins revealed a high degree of amino acid conservation in the structurally critical 
elements of the polypeptide fold suggesting that LACTB forms a similar polypeptide fold.  
Homology modeling of LACTB using the crystal structure of the D-alanyl-D-alanine 
carboxypeptidase from the Streptomyces R61 as a template supported this hypothesis. The 
homology model showed that LACTB shared a similar polypeptide fold consisting of ??? 
region and all-helical region, with the catalytic site located between them (III,  fig.  4  C).  
Additionally  in  the  LACTB model,  the  predicted  coiled-coil  segment  was  located  on  the  
surface of LACTB, permitting formation of a flexible loop. In summary, holomogy 
modeling indicates that LACTB and bacterial LPBP-B proteins share common ancestry 
and features in the 3D structure organization.  
 
5.3 Evolutionary relationship of mammalian LACTB and 
bacterial PBPs 
 
Phylogenetic analysis revealed that the LACTB family is organized into four alloparalogus 
lineages deriving from four separate bacterial LPBP-B subclass genes. Since LACTB 
orthologs clustered together with LPBP-B proteins from free-living ?-proteobacteria, the 
ancestors for the LACTB family most likely were acquired simultaneously from early ?-
proteobacterium. It is possible that these ?-proteobacteria harbored four LPBP-B genes 
encoding structurally related proteins with different biochemical functions. However, 
during eukaryotic evolution some of these genes were eradicated from the ?-
proteobacterial genome following endosymbiosis (Boussau et al., 2004). This would 
explain why LACTB-like proteins 1, in contrast to LACTB-like proteins 2, do not appear 
in nematodes, while LACTB orthologs are widely distributed among the metazoan taxa. In 
addition, the lack of PG synthesis mechanism in metazoans due to a gene loss might 
explain the absence of enzymatic substrates for the LACTB family proteins.  
Nevertheless, the homologs of bacterial PBP/?-lactamases are conserved in eukaryotes 
indicating that the LACTB family proteins play a significant role in eukaryotes. Several 
speculations can be invoked to explain why LACTB has been conserved in eukaryotes.  
First, the phagocytotic feeding and hydrolysis of ingested PG would promote the 
preservation of PBP/?-lactamases genes in early eukaryotes. For example, C. elegans that 
feeds on soil bacteria retained the genes for hydrolysis of ingested PG. Moreover, the 
metabolism of vertebrates is linked to the metabolism of its gut microbe flora that release 
specific microbial metabolites. Germ-free mice colonized with an obese gut microbe 
showed an increase in total body fat which was associated with changes in carbohydrate 
and lipid metabolism (Turnbaugh et al., 2006). Furthermore, the obese microbe flora had 
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an increased efficiency to extract energy from the diet indicating that the gut microbe flora 
can contribute to obesity. According to these observations, a participation of LACTB in the 
metabolism of some yet unidentified substrate(s) deriving from commensal bacteria can 
not be ruled out.  
Second, phagocytosis is a defense mechanism of the innate immune response during a 
pathogen infection. A microorganism infection triggers the innate immune system of a 
vertebrate through germline-encoded pattern-recognition receptors like the Toll-like 
receptors. Toll-like receptors are expressed on various immune cells, including 
macrophages,  B  cells  and  specific  type  T  cells.  These  receptors  are  involved  in  the  
recognition of a variety of bacterial components (Akira et al., 2006). Indeed, the 
lipopolysaccharide of the gut microbiota has been identified as an inflammatory cause for 
insulin resistance, obesity and diabetes diseases (Cani et al., 2007). Lipopolysascharide is 
the major component of the outer membrane of gram-negative bacteria, while PG is a 
major component of the membrane in gram-positive bacteria. Several pieces of evidence 
indicate that PG is a potent immunogen and can trigger innate immune response in 
mammals (Steiner, 2004; Hamilton et al., 2006). Innate immune response in C. elegans has 
been triggered after fungal infection (Pujol et al., 2008). In this study, a PBP homolog 
Lact-1 was up regulated after fungal infection. Pujol et al. speculated that LACT-1 may be 
involved in pathogen recognition. Surprisingly, microarray studies have showed that Lactb 
together with other murine macrophage genes associated with cell growth and metabolism 
was down-regulated after Brucella melitensis bacterial  infection  (He  et  al.,  2006).  These  
bacteria belong to ?-proteobacteria and share similar features such as the phospholipid 
components of the membrane and homologous genes with mitochondria (Ramirez-
Romero, 1998). In addition, these bacteria suppressed expression of the mitochondrial 
genes involved in apoptosis activation. Based on these observations, down-regulation of 
LACTB might be explained by a decreased immunity response of the murine. Altogether, 
data suggest that LACTB has a relevant implication in metabolism and immune response 
of eukaryotes.  
 
5.4 Recombinant LACTB  
 
The expression of recombinant proteins fused to GST in E. coli allows production and 
purification of proteins. Studies have shown that recombinant GST fusion proteins 
expressed in E. coli have similar properties compared to the non-fused GST proteins, can 
be expressed at high levels, and are soluble (Mercado-Pimentel et al., 2002). When 
LACTB was expressed as an N-terminal GST fusion protein, a significant amount of the 
full-length GST-mLACTB was recovered by glutathione-agarose affinity chromatography. 
The FTIR analysis revealed that the GST-mLACTB had an ordered secondary structure. 
However, the GST domain of the GST-mLACTB protein itself contains 49% ?-helices and 
7% ?-sheets (Cardoso et al., 2003), and therefore, the tag might interfere with the results of 
GST-mLACTB FTIR spectrum. The estimated content of ?- and ?-structures in the GST-
mLACTB corresponds to the amount present in the bacterial class C ?-lactamases (Powers 
et al., 2001) suggesting that the GST-mLACTB was properly folded. 
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When LACTB was expressed as a C-terminal GST fusion protein and as an N-terminal 
or C-terminal His6 fusion protein, it underwent proteolytic degradation. Consequently, our 
results indicate that the N-terminal GST tag protected mLACTB from proteolysis. 
Furthermore, these results suggest that the N-terminal mitochondrial targeting sequence 
promoted proteolysis. This could be due to autoproteolysis or proteolysis by bacterial 
proteases. The E. coli strain BL21(DE3) are protease-deficient, therefore, these results 
support autoproteolysis. The autoproteolysis might be a maturation or an activation 
process. It is interesting to note, that the serine protease Omi/HtrA2 can also undergo 
autoproteolysis and this autoproteolytic processing of the recombinant Omi/HrtA2 protein 
depends on the affinity tag position (Savopoulos et al., 2000).  
 
5.5 ?-lactamase activity of LACTB  
 
LACTB belongs to the family of PBP/?-lactamases. ?-lactamases inactivate ?-lactam 
antibiotics by hydrolyzing the peptide bond of the ?-lactam ring (Ghuysen, 1991; Massova 
and Mobashery, 1998). However, the purified GST-mLACTB and endogenous LACTB 
that were tested for ?-lactamase activity demonstrated no catalytic activity.  
First, the absence of enzymatic activity in the GST-mLACTB and the endogenous 
LACTB may be due to experimental conditions. The serine protease Omi/HtrA2 shows 
proteolytic activity at elevated temperatures (Spiess et al., 1999). The catalytic activities of 
GST-mLACTB and endogenous LACTB were tested at room temperature, which possibly 
explains their lack of catalytic activity. Second, the absence of enzymatic activity might be 
due to an incorrect substrate used in the experiment. Instead of ?-lactamase activity, 
LACTB could act as a PBP and catalyze the hydrolysis of the D-alanyl-D-alanyl peptide 
bond. Furthermore, the ?-lactam ring of ?-lactam antibiotics resembles the D-alanyl-D-
alanyl peptide and binds irreversibly to PBPs. Thus, a third reason for the lack of 
enzymatic activity might be explained through the enzyme inactivation. Fourth, 
endogenous LACTB might be inactive and activated only during certain phases of cell 
cycle. It has been shown that Streptoccocus pneumonia PBP1b (Macheboeuf et al., 2005) 
and E. coli PBP3 (Eberhardt et al., 2003) are activated during cell division. Lastly, a fifth 
reason for the lack of endogenous LACTB enzymatic activity might be a posttranslational 
modification. Posttranslational modification of proteins by phosphorylation can alter the 
protein-protein interactions and the enzymatic activity (Lee et al., 2007). For example, the 
serine protease activity of Omi/HtrA2 is attenuated through the phosphorylation of Ser212 
(Yang et al., 2007). Mitochondrial phosphoproteome studies revealed that the catalytic 
serine residue located in the -SISK- motif of LACTB is phosphorylated under normal 
conditions (Lee et al., 2007). Therefore, questions whether the posttranslational 
modification by phosphorylation may inhibit the LACTB enzymatic activity and what 
factors activate LACTB remain unanswered. 
An esterase from Burkholderia gladioli (EstB) also belongs to the class of hydrolases, 
contains characteristic ?-lactamase motifs, and displays homology to PBP/?-lactamases 
(Petersen et al., 2001; Weisberg et al., 2003). Site directed mutagenesis generated a variant 
in which the catalytic residue is located within the ?-lactamase motif; however, EstB 
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shows no peptidase activity. Surprisingly, it is able to hydrolyze short-chain fatty acid 
esters and triglycerides. It is interesting to note that the polymorphism of LACTB is 
associated with an allergy to penicillin (Apter et al., 2008). Recent studies have shown that 
?-lactam antibiotics are potential therapeutic drugs to treat some neurological disorders 
like ischemia or amyotropic lateral sclerosis (Rothstein et al., 2005; Chu et al., 2006). 
However, it remains to be elucidated if LACTB plays a role in mediating the 
neuroprotective effect of ?-lactam antibiotics. Further experimental studies are required to 
characterize the catalytic activity of LACTB in order to reveal if LACTB also has an 
enzymatic function. 
 
5.6 Subcellular and submitochondrial localization of a soluble 
LACTB  
 
The  subcellular  localization  of  the  protein  might  give  an  important  clue  about  its  
physiological function. Immunoblotting of a rat liver subfractions indicated that LACTB 
was localized in mitochondria. Investigation of submitochondrial localization of LACTB 
by immunoblotting revealed that LACTB like OPA1 and AIF is localized in the 
mitochondrial intermembrane space. Immunoelectron microscopy experiments confirmed 
submitochondrial localization of LACTB. Further studies done by colleagues (N. Peitsaro, 
A. Dapkunas, M. Linder) supported the results that LACTB is a mitochondrial protein. The 
immunocytochemistry experiments on HeLa cells expressing mtRFP revealed that 
endogenous LACTB and mtRFP shared a similar intracellular distribution (III, fig. 1A). In 
addition, a full-length LACTB and a truncated LACTB which lacks N-terminal 97 amino 
acids were fused to C-terminal GFP tag and expressed in HeLa mtRFP cells. The 
expression results demonstrated that the mitochondrial import of LACTB depends on its 
N-terminal amino acid sequence (III, fig. 1B). Immunoblotting of LACTB association 
with mitochondrial membranes revealed that LACTB is a soluble protein. Collectively, 
these results demonstrate that LACTB is a soluble mitochondrial intermembrane space 
protein.  
In contrast to our experimental evidence, LACTB has been detected in mitochondria as 
part of a mitochondrial ribosomal complex (Koc et al., 2001). In this study mitochondrial 
ribosomes were purified from bovine liver by sucrose gradient centrifugation and all the 
identified proteins of unknown function were classified as ribosomal proteins. We propose 
that due to a similar sedimentation coefficient the LACTB migrated with the mitochondrial 
ribosomes.  
 
5.7 Expression of LACTB mRNA and protein 
 
The results of LACTB mRNA expression indicated that LACTB is expressed in all normal 
human tissues. The highest expression level of LACTB mRNA was observed in tissues 
having a high rate of oxidative metabolism suggesting that LACTB is linked to 
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mitochondrial function. Most cancer cell lines have an increased rate of glycolysis, an 
impaired oxidative phosphorylation, and are resistant to apoptosis (Gogvadze et al., 2008). 
The lower levels of LACTB mRNA in several cancer cell lines support the role of LACTB 
in energy metabolism. Altogether, the presence of LACTB in all tissues suggests that 
LACTB may be involved in essential cellular functions.  
The results of LACTB protein expression in rat showed a different tissue distribution 
pattern. Conversely to high LACTB mRNA levels in the heart, skeletal muscle and brain of 
human tissues and rat tissues (A. Dapkunas data), the expression level of the LACTB 
protein was low in mitochondria of these tissues under our experimental conditions. These 
results suggest that LACTB might undergo different processing pathways in the heart, 
skeletal muscle and brain. 
A first explanation for a lack of correlation between the mRNA abundance and the 
protein absence might involve different half-lives of proteins due to varied protein 
synthesis and degradation. A second reason for the different expression levels of mRNA 
and protein might be explained by posttranslational modifications associated with the 
production of protein from mRNA (Greenbaum et al., 2003). A posttranslational 
modification like lysine acetylation may regulate transcription, protein activity and 
stability. A recent study revealed that the lysine residue of LACTB is acetylated during 
starvation  (Kim  et  al.,  2006).  It  is  interesting  to  note,  that  a  variety  of  mitochondrial  
metabolic enzymes such as NADH dehydrogenase, isocitrate dehydrogenase, ATP 
synthase or glutamate dehydrogenase were also lysine-acetylated. This observation 
suggests that posttranslational lysine acetylation might regulate the activity of LACTB. 
However, no significant difference was observed in the expression level of the LACTB 
protein between starved and fed rats. In contrast, ethanol had a profound effect on the 
LACTB protein expression level in liver. The metabolic consequence of ethanol is the 
increased lipogenesis, an impaired fatty acid oxidation and triglyceride elimination (You 
and Crabb, 2004). Additional experiments are needed to investigate the relationships 
between ethanol, nutritional state and LACTB protein level.  
It has been shown that insulin increases the LACTB mRNA level in human skeletal 
muscle (Rome et al., 2003). In skeletal muscle, insulin modulates the mRNA level of some 
important genes like hexokinase II, Glut4, phosphatidylinositol 3-kinase, or lipoprotein 
lipase involved in glucose and lipid metabolism pathways (Laville et al., 1996; Pentergass 
et al., 1998; Rome et., 2003). Impaired glucose transport and lipid metabolism due to the 
elevated levels of fatty acid metabolites cause insulin resistance (Lowell et al., 2005). In 
turn, the insulin resistance may lead to type 2 diabetes which is usually associated with 
obesity (Kahn et al., 2006; Muoio and Newgard, 2008). Analysis of adipose tissue 
transcription profile of obese co-twins showed that genes involved in the mitochondrial 
branched-chain amino acid catabolism, fatty acid synthesis and ?-oxidation pathways were 
down-regulated (Pietiläinen et al., 2008). Recently, Llp and Lactb were validated as obesity 
genes in complex metabolic disease traits (Chen et al., 2008). Llp knockout and Lactb 
transgenic mice had 20% increases in fat mass compared to the lean controls. Based on the 
evidence that the lipoprotein lipase is responsible for the hydrolysis of triglycerides into 
glycerol and fatty acids (Preiss-Landl et al., 2002), LACTB possibly is involved in fatty 
acid metabolism. Indeed, most recent studies analyzing altered genes in Lactb transgenic 
mice showed down regulation of fatty acid metabolic pathway (Yang et al., 2009). 
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5.8 Proteolytic processing of LACTB  
 
The majority of nucleus-encoded mitochondrial proteins are translated on cytosolic 
ribosomes as precursors with N-terminal presequences that are proteolyticaly removed by 
specific processing peptidases during mitochondrial import (Gakh et al., 2002). Our results 
show that a 55 kDa mature LACTB is formed by the removal of 62 amino acids from the 
N-terminus of the LACTB preprotein. This proteolytic cleavage results in the N-terminus 
sequence starting from the amino acids: alanine, valine, proline, and isoleucine (AVPI). A 
hydrophobic sorting signal located in the presequence close to the cleavage site of the 
LACTB preprotein suggests that LACTB is processed by two-step cleavage: first, the 
matrix-targeting presequence is cleaved by mitochondrial processing peptidase; second, the 
intermembrane space-sorting signal is removed by the inner membrane peptidase.  
For example, the Omi/HtrA2 precursor protein is imported into mitochondria, the 
hydrophobic transmembrane domain arrests it in the IMM, and the mitochondrial 
processing peptidases release a soluble mature Omi into the intermembrane space 
(Kadomatsu et al., 2007). LACTB like Omi/HtrA2 has a prokaryotic origin, belongs to the 
serine protease family, and is located in the mitochondrial intermembrane space 
(Vandenabeele et al., 2005; Vande Walle et al., 2008). It is possible that LACTB and 
Omi/HtrA2 proteins share similar mitochondrial import and processing pathways.  
A data base analysis of the LACTB sequence predicts that the mitochondrial processing 
peptidases would recognize R61 and cleave at the G62 site. It is noteworthy that this 
cleavage discloses an N-terminal tetrapetide motif also found in a set of pro-apoptotic IAP 
antagonists (Eckelman et al., 2008). Pro-apoptotic IAP antagonists can bind to the BIRs via 
this N-terminal tetrapeptide motif and release active caspases (Liu, 2000; Wu, 2000). 
Proteins that bind to BIRs in an N-terminal IAP binding motif-dependent manner include: 
caspases (Srinivasula et al., 2001), Drosophila proteins Hid, Grim and Reaper (Bangs et 
al., 2000), Smac/Diablo (Verhagen et al., 2000), Omi/HtrA2 (Hegde et al., 2002), 
glutamate dehydrogenase (GDH), Nipsnap 3 and 4, leucine-rich pentatricopeptide motif-
containing protein (LRPPR), and 3-hydroxyisobutyrate dehydrogenase (Verhagen et al., 
2007) (fig. 14).  
 
 
Fig. 14. Comparison of N-terminal 
tetrapeptide motif in mammalian and 
Drosophila IAP binding proteins. Grey 
background represents identical amino acids. 
ClpX is a regulatory component of the 
mitochondrial Clp protease; GSPT/eRF3 is 
an endoplasmic reticulum associated protein. 
Figure modified from Verhagen et al., 2007. 
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Remarkably, LACTB groups together with these pro-apoptotic IAP antagonists 
suggesting that LACTB could interact with the BIR domain of IAPs, although, this 
hypothesis needs further studies. 
All known mammalian IAP binding proteins, except Smac/Diablo, appear to have other 
essential functions in the cell (Verhagen et al., 2007). Omi/HtrA2 acts as a chaperone 
(Speiss et al., 1999), LRPPR is responsible for mitochondrial RNA transcript processing 
(Mili and Pinol-Roma, 2003), while GDH and 3-hydroxyisobutyrate dehydrogenase are 
mitochondrial metabolic enzymes. Therefore, LACTB might also have multiple functions: 
(i) interaction with proteins involved in apoptosis through its N-terminal tetrapeptide motif 
and (ii) participation in metabolic signaling processes (Rome et al., 2003; Chen et al., 
2008). In support of the first notion is the experimental evidence that apoptosis induces 
macrophage death after the phagocytosis of extracellular bacteria (Frankenberg et al., 
2008).  We  can  speculate  that  LACTB,  in  addition  to  its  hypothetical  role  in  the  PG  
degradation, may act as an apoptosis-inducing signal in phagocytes. 
 
5.9 High molecular weight complex – polymeric filaments  
 
Analysis of mitochondrial intermembrane space proteins by 2D BN SDS-PAGE revealed 
that LACTB is a component of a multiprotein complex or it exists in a homopolymeric 
form. Most in vivo transient protein-protein interactions occur briefly to facilitate signaling 
or metabolic functions, while long-lasting protein-protein interactions favor a protein 
complex formation. Several proteins including GDH, carbamoylphosphate synthase, and 
the ribosomal subunits 60L and 40L co-migrated with LACTB. Carbamoylphosphate 
synthase and GDH are highly abundant proteins in liver mitochondria and like cytosolic 
ribosomal proteins may represent contaminants. Therefore, these findings support the 
hypothesis that LACTB forms a homopolymer. However, GDH has been observed to be 
released following tBid treatment of the liver mitochondria (Van Loo et al., 2002). This 
study suggests that part of the protein might be localized in the mitochondrial 
intermembrane space or is released under certain conditions from the matrix. Furthermore, 
a proteomics study of the mouse liver IMM revealed matrix proteins in their precursor 
form suggesting that the N-terminal targeting signals of these proteins had not yet been 
processed by mitochondrial matrix peptidase (Cruz et al., 2003). Interestingly, most 
proteins that co-migrated with LACTB participate in metabolic processes: 
carbamoylphosphate synthase participates in urea cycle, and GDH is a key regulatory 
enzyme in glutamate metabolism.  
The hypothesis that LACTB forms a homopolymer was confirmed by EM studies. A 
CsCl-gradient fraction containing LACTB analyzed by EM revealed organized filaments. 
The heterogenous size of filaments suggested that a broad molecular mass range of 
LACTB upon electrophoretic separation might represent these filaments. Furthermore, 
results from the whole-mount immunoelectron microscopy confirmed that LACTB was a 
component of the filament. Based on analysis of the subunit organization of the LACTB 
filament, one subunit can accommodate 3-5 molecules of LACTB. These results suggest 
that the molecular weight of a subunit is 150-200 kDa. According to the molecular weight 
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of 200 kDa observed for the minor LACTB band upon electrophoresis, it is likely that 
LACTB polymer forms a homotetramer. Altogether, these results demonstrate that LACTB 
can polymerize and form a filament with an open symmetry. Homotrimerization of 
Omi/HtrA2 is mediated exclusively by the N-terminal region of the protease domain (Li et 
al., 2002). The oligomeric state of Omi/HtrA2 is essential for the serine protease activity 
suggesting that LACTB may also require polymerization for enzymatic activity. 
Similar filaments were detected in the intracristal region of the intermembrane space of 
chemically fixed mitochondria by EM indicating that polymeric LACTB filaments exist in 
the intact mitochondria (III, fig. 3C). The results of immunoelectron microscopy of 
isolated mitochondria confirmed that LACTB formed clusters in the intermembrane space; 
however, this sample preparation method was unsuccesful to reveal the ultrastructure of 
the LACTB filament. Filaments observed in mitochondria were composed of globular 
subunits and resembled polymeric LACTB filaments. Measurements performed on these 
filaments and on LACTB polymers displayed a similar thickness and repeat distance (III). 
These results suggest that the isolated LACTB filaments and the intramitochondrial 
filaments represent the same structure. Furthermore, the observation that LACTB polymers 
can form in situ suggest that the ordered polymerization process of LACTB has a specific 
physiological function.  
Our studies revelead that LACTB filaments localized preferentially in the intracristal 
region of the intermembrane space and had its ends tethered to the IMM (III, fig. 3C). 
Submitochondrial inner membrane vesicles which contain only membrane components and 
membrane-bound macromolecules (III, supplementary fig. S5) were chemically fixed and 
analyzed by EM. The results showed that submitochondrial inner membrane vesicles 
contained filaments tethered to the membrane of vesicle by its ends (III, fig. 3D). In 
conclusion, LACTB filaments form a stable module via interactions with IMM 
components proposing that LACTB has a structural function. In support of this notion is 
experimental evidence of quantitative immunobloting indicating that LACTB is abundant 
protein and therefore it has the potential to impact mitochondrial ultrastructure. 
Consequently, the question has arisen as to if these filaments have been visualized by 
others. Indeed, similar helical filaments have been observed in early EM studies of 
mitochondria (Sasaki et al., 1991; Tandler et al., 1996). The helical filaments were 
localized in the mitochondrial intermembrane space of different tissues in a variety of 
species. The dimensional parameters of the intramitochondrial helical filaments 
corresponded well in the various cell types (Sasaki et al., 1991). According to discussions 
in previous reports, it was proposed that the helical filaments are composed of lipids or 
phospholipids (Svoboda and Higginson, 1964), or DNA-protein complexes (Mugaini and 
Walberg, 1964; Jessen, 1968). Other authors considered that helical filaments in 
mitochondria may emerge in consequence of a special metabolism or a metabolic disorder 
that result in the accumulation of abnormal proteinaceous substances that aggregate into 
helical filaments. Dysregulation of metabolism or metabolic disorders due to protein 
deficiency (Behnke, 1965), alcoholism (Iseri et al., 1966), and certain renal diseases in 
human (Suzuki et al., 1975) may cause mitochondria to synthesize the helical filaments 
(Sasaki and Suzuki, 1989; Sasaki et al., 1995). An indication that LACTB is related to 
metabolic disorders (Schadt et al., 2005; Chen et al., 2008; Yang et al., 2009) might 
support the hypothesis that metabolism dysregulation is the cause for the appearance of 
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filaments. Therefore, it is of interest to investigate if these helical filaments are present in 
obesity models.  
Several groups, including ours, have seen filaments under normal conditions (Mugnaini 
and Walberg, 1964; Svoboda and Higginson, 1964) indicating that these filaments are not 
merely pathological products in the mitochondria. Filaments have been detected only in 
some parts of the mitochondria population within one cell suggesting that the filaments are 
related to a particular phase in the life of the organelle.  
It should be noted, that the IMM shows a dynamic subcompartmentalization where 
proteins redistribute between inner boundary membrane and crista membrane depending 
on the physiological state of the cell (Volgel et al., 2006). The crista represents a sink for 
metabolites, proteins and assembly intermediates of respiratory supracomplexes (Mannella, 
2006; Volgel et al., 2006). Studies revealed that ATP synthase and complex III are 
assembled on the crista membrane trapping the protons inside the cristae (Gilkerson et al., 
2003; Strauss et al., 2008). The compartmentation of protons and ADP allows an efficient 
electron transfer and respiration. Furthermore, the topology of the inner membrane might 
influence mitochondrial functions. In addition to ATP synthase, tBid, AIF, and OPA1 
oligomers can modulate the crista morphology. For example, aberrant and dilated cristae 
have been observed in mitochondria of AIF deficient neurons (Cheung et al., 2006). OPA1 
controls apoptotic crista remodeling by segregating the cytochrome c in the intracristal 
space (Frezza et al., 2006). Thus compartmentation of the LACTB together with the 
metabolites and the proteins involved in apoptosis suggest that LACTB might play a role 
in core energy metabolism and apoptotic process.  
Interestingly, Mootha’s group assigned LACTB as a possible respiratory complex I-
associated protein through phylogenetic profiling (Pagliarini et al, 2008). Our phylogenetic 
study supports the notion that S. cerevisiae, lacking respiratory chain complex I, has no 
homologs of LACTB. A link between LACTB and several other potential complex I-
associated proteins, involved in branched-chain amino acid catabolism and lipid 
breakdown, further underscore the importance of LACTB in metabolic pathways.  
The mitochondrial membrane architecture is highly dynamic, undergoing ultrastructural 
rearrangement in response to the metabolic (Hackenbrock, 1968), cell proliferation and 
death signals (Scorrano et al, 2002; Sun et al., 2007). It has been indicated that proteins 
involved in organizing the bacterial shape and division show homology to the eukaryotic 
cytoskeletal proteins such as actin, tubulin and intermediate filaments (review by Cabeen 
and Jacob-Wagner, 2005). Therefore, the question has risen if bacterial cytoskeletal 
proteins are linked to the PG synthesis machinery. Cabee and Jacob-Wagner suggested that 
PBPs might be a molecular link between the bacterial cytoskeleton and PG. Interestingly, 
during evolution green plants preserved some bacterial PG genes in chloroplasts. It was 
revealed that genes responsible for the PG synthesis pathway are essential for chloroplast 
division in moss (Machida et al., 2006). Both chloroplast and mitochondria evolved 
through endosymbiosis. Structural proteins like actin, tubulin and intermediate filaments 
form polymers with an open symmetry. Based on these studies, the finding that LACTB 
can form homopolymers suggests that LACTB possibly has a structural role in the 
organization of the mitochondrial supramolecular architecture. We propose that 
compartmentalized LACTB probably together with some other proteins forms a dynamic 
molecular scaffold, promoting metabolon assembly. The potential role of LACTB in the 
metabolon assembly might be associated with organizing enzymes for fatty acid 
 
 
56 
metabolism. We can speculate that LACTB might be involved in the regulation of the 
mitochondrial carnitine system, which is responsible for the fatty acid transport to 
mitochondria (Kerner and Hoppel, 2000). In support of this hypothesis is the observation 
that cystoskeletal proteins regulate carnitine palmitoyltranferase I activity (Velasco et al., 
1998). In conclusion, our findings underscore the significance of the mitochondrial 
intermembrane space integrity for coordination processes governing both cell proliferation 
and death.  
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6. CONCLUSIONS AND FUTURE PERSPECTIVES 
 
Based on the main findings of this thesis, we can conclude the following: 
? The full-length N-terminal GST fusion protein was obtained indicating that 
the expression of the Lactb gene in E. coli was successful. 
? LACTB  is  conserved  from  bacteria  to  humans.  LACTB  has  evolved  from  
the penicillin binding-proteins present in the bacterial periplasmic space.  
? LACTB is expressed in all normal tissues suggesting that LACTB is 
involved in regulating essentianl cellular functions. 
? LACTB is a soluble protein localized in the mitochondrial intermembrane 
space. The mitochondrial import of LACTB depends on the N-terminal 
amino acid sequence of the protein. 
? Proteolytic processing of LACTB discloses an N-terminal tetrapeptide motif 
shared by other mitochondrial proteins involved in apoptotic signal 
transduction. 
? LACTB  can  polymerize  to  form  filaments,  possibly  together  with  other  
protein(s). LACTB filaments demarcate a distinct mitochondrial 
microdomain. A potential role of the LACTB filaments is suggested in 
mitochondrial intermembrane space organization and/or mitochondrial 
metabolic signaling. 
 
The importance of Lactb, as a new obesity-inducing gene, was revealed in a survey of 
complex disease traits (Schadt et al., 2005; Yang et al., 2009). Based on our findings, we 
propose that LACTB have multiple functions in mitochondria – (i) impact mitochondrial 
ultrastructure, (ii) involved in metabolism and (iii) associated with apoptosis sensing.  
Structural proteins control cell shape and cell division of eukaryotes and prokaryotes 
(Amos et al., 2004). PBPs are required for bacteria and moss chloroplast division (Morlot 
et al., 2004; Machida et al., 2006). Mammalian mitochondria undergo structural changes 
during apoptosis (Delivani and Martin, 2006; Sun et al., 2007). These evident propose that 
LACTB filaments are involved in the dynamics of the mitochondrial intermembrane space. 
The role of LACTB in fusion-fission events remains a challenging hypothesis that needs to 
be further investigated.  
Increasing evidences show that cellular metabolism and cell survival are regulated by 
growth factors that modulate the function of proteins involved in glucose metabolism and 
apoptosis (Hammerman et al., 2004; Heiden et al., 2001). Therefore, the main question 
arises whether there is a link between LACTB, mitochondrial ultrastructure, metabolism 
and apoptosis processes (fig. 15).  
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Fig. 15. Triangle – a potential role of LACTB in cell processes.  
An additional hypothesis could be addressed for further understanding the function of 
LACTB in obesity metabolic disorder caused by inflammatory factors. The major 
components of the bacterial cell wall, lipopolysaccharide and PG, trigger an immune 
response in mammals (Hamilton et al., 2006; Cani et al., 2007) suggesting that LACTB 
could be implicated in innate immunity. 
Further studies may answer some important questions: what benefit does the eukaryotic 
cell gain by retaining the LACTB, what triggers LACTB polymerization, what enzymatic 
substrate(s) does LACTB metabolize. Detailed knowledge of the LACTB function might 
offer a tool to treat mitochondria-related diseases. It is evident that LACTB is a protein that 
merits further study.  
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